<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Eur J Ageing</journal-id><journal-id journal-id-type="iso-abbrev">Eur J Ageing</journal-id><journal-title-group><journal-title>European Journal of Ageing</journal-title></journal-title-group><issn pub-type="ppub">1613-9372</issn><issn pub-type="epub">1613-9380</issn><publisher><publisher-name>Springer Netherlands</publisher-name><publisher-loc>Dordrecht</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">40000465</article-id><article-id pub-id-type="pmc">PMC11861444</article-id>
<article-id pub-id-type="publisher-id">837</article-id><article-id pub-id-type="doi">10.1007/s10433-025-00837-1</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title>The potential of depressive symptoms to identify cognitive impairment in ageing</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Alexopoulos</surname><given-names>Panagiotis</given-names></name><address><email>panos.alexopoulos@upatras.gr</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff3">3</xref><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Bountoulis</surname><given-names>Christos</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name><surname>Katirtzoglou</surname><given-names>Everina</given-names></name><xref ref-type="aff" rid="Aff6">6</xref></contrib><contrib contrib-type="author"><name><surname>Kosmidis</surname><given-names>Mary H.</given-names></name><xref ref-type="aff" rid="Aff7">7</xref></contrib><contrib contrib-type="author"><name><surname>Siarkos</surname><given-names>Kostas</given-names></name><xref ref-type="aff" rid="Aff6">6</xref></contrib><contrib contrib-type="author"><name><surname>Yannakoulia</surname><given-names>Mary</given-names></name><xref ref-type="aff" rid="Aff8">8</xref></contrib><contrib contrib-type="author"><name><surname>Dardiotis</surname><given-names>Efthimios</given-names></name><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author"><name><surname>Skondra</surname><given-names>Maria</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Hadjigeorgiou</surname><given-names>Georgios</given-names></name><xref ref-type="aff" rid="Aff9">9</xref><xref ref-type="aff" rid="Aff10">10</xref></contrib><contrib contrib-type="author"><name><surname>Perneczky</surname><given-names>Robert</given-names></name><xref ref-type="aff" rid="Aff11">11</xref><xref ref-type="aff" rid="Aff12">12</xref><xref ref-type="aff" rid="Aff13">13</xref><xref ref-type="aff" rid="Aff14">14</xref><xref ref-type="aff" rid="Aff15">15</xref></contrib><contrib contrib-type="author"><name><surname>Sakka</surname><given-names>Paraskevi</given-names></name><xref ref-type="aff" rid="Aff16">16</xref></contrib><contrib contrib-type="author"><name><surname>Georgiou</surname><given-names>Eleni-Zacharoula</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Charalampopoulou</surname><given-names>&#x0039c;arina</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Felemegkas</surname><given-names>Panagiotis</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Leroi</surname><given-names>Iracema</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Batsidis</surname><given-names>Apostolos</given-names></name><xref ref-type="aff" rid="Aff17">17</xref></contrib><contrib contrib-type="author"><name><surname>Perna</surname><given-names>Laura</given-names></name><xref ref-type="aff" rid="Aff18">18</xref></contrib><contrib contrib-type="author"><name><surname>Politis</surname><given-names>Antonios</given-names></name><xref ref-type="aff" rid="Aff6">6</xref><xref ref-type="aff" rid="Aff19">19</xref></contrib><contrib contrib-type="author"><name><surname>Scarmeas</surname><given-names>Nikolaos</given-names></name><xref ref-type="aff" rid="Aff20">20</xref><xref ref-type="aff" rid="Aff21">21</xref></contrib><contrib contrib-type="author"><name><surname>Economou</surname><given-names>Polychronis</given-names></name><xref ref-type="aff" rid="Aff22">22</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/017wvtq80</institution-id><institution-id institution-id-type="GRID">grid.11047.33</institution-id><institution-id institution-id-type="ISNI">0000 0004 0576 5395</institution-id><institution>Department of Medicine, School of Health Sciences, </institution><institution>Mental Health Services, Patras University General Hospital, University of Patras, </institution></institution-wrap>26504 Rio, Patras, Greece </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/02tyrky19</institution-id><institution-id institution-id-type="GRID">grid.8217.c</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 9705</institution-id><institution>Global Brain Health Institute, Medical School, </institution><institution>Trinity College Dublin, </institution></institution-wrap>Dublin, Republic of Ireland </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/02kkvpp62</institution-id><institution-id institution-id-type="GRID">grid.6936.a</institution-id><institution-id institution-id-type="ISNI">0000000123222966</institution-id><institution>Department of Psychiatry and Psychotherapy, Klinikum Rechts der Isar, Faculty of Medicine, </institution><institution>Technical University of Munich, </institution></institution-wrap>Munich, Germany </aff><aff id="Aff4"><label>4</label>Patras Dementia Day Care Center, Patras, Greece </aff><aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/02qs84g94</institution-id><institution-id institution-id-type="GRID">grid.4463.5</institution-id><institution-id institution-id-type="ISNI">0000 0001 0558 8585</institution-id><institution>Department of Business Administration, </institution><institution>University of Piraeus, </institution></institution-wrap>Piraeus, Greece </aff><aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/04gnjpq42</institution-id><institution-id institution-id-type="GRID">grid.5216.0</institution-id><institution-id institution-id-type="ISNI">0000 0001 2155 0800</institution-id><institution>1st Department of Psychiatry, Eginition Hospital, School of Medicine, </institution><institution>National and Kapodistrian University of Athens, </institution></institution-wrap>Athens, Greece </aff><aff id="Aff7"><label>7</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/02j61yw88</institution-id><institution-id institution-id-type="GRID">grid.4793.9</institution-id><institution-id institution-id-type="ISNI">0000 0001 0945 7005</institution-id><institution>Lab of Cognitive Neuroscience, School of Psychology, </institution><institution>Aristotle University of Thessaloniki, </institution></institution-wrap>Thessaloniki, Greece </aff><aff id="Aff8"><label>8</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/02k5gp281</institution-id><institution-id institution-id-type="GRID">grid.15823.3d</institution-id><institution-id institution-id-type="ISNI">0000 0004 0622 2843</institution-id><institution>Department of Nutrition and Dietetics, </institution><institution>Harokopio University, </institution></institution-wrap>Athens, Greece </aff><aff id="Aff9"><label>9</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/04v4g9h31</institution-id><institution-id institution-id-type="GRID">grid.410558.d</institution-id><institution-id institution-id-type="ISNI">0000 0001 0035 6670</institution-id><institution>Department of Neurology, Larissa University General Hospital, School of Medicine, </institution><institution>University of Thessaly, </institution></institution-wrap>Larissa, Greece </aff><aff id="Aff10"><label>10</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/02qjrjx09</institution-id><institution-id institution-id-type="GRID">grid.6603.3</institution-id><institution-id institution-id-type="ISNI">0000 0001 2116 7908</institution-id><institution>Department of Neurology, Medical School, </institution><institution>University of Cyprus, </institution></institution-wrap>Nicosia, Cyprus </aff><aff id="Aff11"><label>11</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/05591te55</institution-id><institution-id institution-id-type="GRID">grid.5252.0</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 973X</institution-id><institution>Division of Mental Health in Older Adults and Alzheimer Therapy and Research Center, Department of Psychiatry and Psychotherapy, </institution><institution>University Hospital, Ludwig-Maximilians-Universit&#x000e4;t Munich, </institution></institution-wrap>Munich, Germany </aff><aff id="Aff12"><label>12</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/041kmwe10</institution-id><institution-id institution-id-type="GRID">grid.7445.2</institution-id><institution-id institution-id-type="ISNI">0000 0001 2113 8111</institution-id><institution>Ageing Epidemiology (AGE) Research Unit, School of Public Health, Faculty of Medicine, </institution><institution>The Imperial College of Science, Technology and Medicine, </institution></institution-wrap>London, UK </aff><aff id="Aff13"><label>13</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/043j0f473</institution-id><institution-id institution-id-type="GRID">grid.424247.3</institution-id><institution-id institution-id-type="ISNI">0000 0004 0438 0426</institution-id><institution>German Center for Neurodegenerative Diseases (DZNE) Munich, </institution></institution-wrap>Munich, Germany </aff><aff id="Aff14"><label>14</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/025z3z560</institution-id><institution-id institution-id-type="GRID">grid.452617.3</institution-id><institution>Munich Cluster for Systems Neurology (SyNergy), </institution></institution-wrap>Munich, Germany </aff><aff id="Aff15"><label>15</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/05krs5044</institution-id><institution-id institution-id-type="GRID">grid.11835.3e</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 9262</institution-id><institution>Sheffield Institute for Translational Neurosciences (SITraN), </institution><institution>University of Sheffield, </institution></institution-wrap>Sheffield, UK </aff><aff id="Aff16"><label>16</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/04xqgyf78</institution-id><institution-id institution-id-type="GRID">grid.428867.7</institution-id><institution>Athens Association of Alzheimer&#x02019;s Disease and Related Disorders, </institution></institution-wrap>Maroussi, Greece </aff><aff id="Aff17"><label>17</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01qg3j183</institution-id><institution-id institution-id-type="GRID">grid.9594.1</institution-id><institution-id institution-id-type="ISNI">0000 0001 2108 7481</institution-id><institution>Department of Mathematics, </institution><institution>University of Ioannina, </institution></institution-wrap>Ioannina, Greece </aff><aff id="Aff18"><label>18</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/04dq56617</institution-id><institution-id institution-id-type="GRID">grid.419548.5</institution-id><institution-id institution-id-type="ISNI">0000 0000 9497 5095</institution-id><institution>Department of Genes and Environment, </institution><institution>Max Planck Institute of Psychiatry, </institution></institution-wrap>Munich, Germany </aff><aff id="Aff19"><label>19</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00za53h95</institution-id><institution-id institution-id-type="GRID">grid.21107.35</institution-id><institution-id institution-id-type="ISNI">0000 0001 2171 9311</institution-id><institution>Department of Psychiatry, Division of Geriatric Psychiatry and Neuropsychiatry, </institution><institution>Johns Hopkins Medical School, </institution></institution-wrap>Baltimore, USA </aff><aff id="Aff20"><label>20</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/03wed5r38</institution-id><institution-id institution-id-type="GRID">grid.414406.3</institution-id><institution>1st Department of Neurology, </institution><institution>Eginition Hospital, National and Kapodistrian University of Athens Medical School, </institution></institution-wrap>Athens, Greece </aff><aff id="Aff21"><label>21</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00hj8s172</institution-id><institution-id institution-id-type="GRID">grid.21729.3f</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 8729</institution-id><institution>Department of Neurology, Taub Institute for Research in Alzheimer&#x02019;s Disease and the Ageing Brain, The Gertrude H. Sergievsky Center, </institution><institution>Columbia University, </institution></institution-wrap>New York, NY USA </aff><aff id="Aff22"><label>22</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/017wvtq80</institution-id><institution-id institution-id-type="GRID">grid.11047.33</institution-id><institution-id institution-id-type="ISNI">0000 0004 0576 5395</institution-id><institution>Department of Civil Engineering, School of Engineering, </institution><institution>University of Patras, </institution></institution-wrap>Patras, Greece </aff></contrib-group><author-notes><fn fn-type="com"><p>Responsible Editor: Matthias Kliegel.</p></fn></author-notes><pub-date pub-type="epub"><day>25</day><month>2</month><year>2025</year></pub-date><pub-date pub-type="pmc-release"><day>25</day><month>2</month><year>2025</year></pub-date><pub-date pub-type="collection"><month>12</month><year>2025</year></pub-date><volume>22</volume><issue>1</issue><elocation-id>7</elocation-id><history><date date-type="accepted"><day>7</day><month>1</month><year>2025</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2025</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><abstract id="Abs1"><p id="Par1">Depressive symptoms are common in mild cognitive impairment (MCI), dementia caused by Alzheimer&#x02019;s disease (AD dementia) and in cognitively unimpaired older adults. However, it is unclear whether they could contribute to the identification of cognitive impairment in ageing. To assess the potential utility of depressive symptoms to distinguish between healthy cognitive ageing and MCI and AD dementia. The diagnostic workup of the cognitive function of 1737 older cognitively unimpaired individuals, 334 people with MCI and 142 individuals with AD dementia relied on a comprehensive neuropsychiatric assessment, including the Mini Mental State Examination (MMSE). Depressive symptoms were tapped with the 15-item Geriatric Depression Scale (GDS). Proportional odds logistic regression (POLR) models and the machine learning technique Adaptive Boosting algorithm (AdaBoost) were employed. Stratified repeated random subsampling (stratified bootstrap resampling) was used to recursive partitioning to training- and validation set (70/30 ratio). The average accuracy of the POLR models for the GDS total score in distinguishing between cognitive impairment and healthy cognitive ageing exceeded 78% and was inferior to that of MMSE. Of note, the sensitivity of GDS total score was very low. By employing the AdaBoost algorithm and considering GDS items separately, the average accuracy was higher than 0.72 and comparable to that of the MMSE, while sensitivity- and specificity values were more balanced. The findings of the study provide initial evidence that depressive symptoms may contribute to distinguishing between cognitive impairment and cognitively healthy ageing.</p><sec><title>Supplementary Information</title><p>The online version contains supplementary material available at 10.1007/s10433-025-00837-1.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Geriatric depression scale</kwd><kwd>Adaptive boosting algorithm</kwd><kwd>Mild cognitive impairment</kwd><kwd>Dementia due Alzheimer&#x02019;s disease</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; Springer Nature B.V. 2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Background</title><p id="Par2">Depressive symptoms are common across the entire spectrum of cognitive ageing. Worldwide the average prevalence in older individuals is about 32% (Zenebe et al. <xref ref-type="bibr" rid="CR51">2021</xref>). Among older people with cognitive deficits, which do not severely hamper performance on activities of daily living, (mild cognitive impairment; MCI), the prevalence of depressive symptoms is estimated to be 25% in community-based and 40% in clinic-based samples (Ismail et al. <xref ref-type="bibr" rid="CR22">2017</xref>). The prevalence rate of depressive symptoms in people with dementia is roughly 40% (Helvik et al. <xref ref-type="bibr" rid="CR20">2019</xref>; (Eliza) Georgiou et al. <xref ref-type="bibr" rid="CR18">2023</xref>). Interestingly, the most common alterations associated to late-life depression, such as neurotransmitter imbalance, hypothalamus&#x02013;pituitary&#x02013;adrenal (HPA) axis dysregulation, reduction of nerve growth factors, vascular disease and neuroinflammation are linked to pathological changes in the ageing brain, including Alzheimer&#x02019;s disease (AD)-related pathology (amyloid accumulation, tau aggregation, neurodegeneration), and cerebrovascular pathologies, which often co-exist (Rahimi and Kovacs <xref ref-type="bibr" rid="CR38">2014</xref>; Alexopoulos <xref ref-type="bibr" rid="CR3">2019</xref>). Additionally, cortical amyloid load is higher in older people with depression and no dementia than in older individuals with neither dementia nor depression and the association between severity of depression and amyloid load follows a dose&#x02013;response pattern (Smith et al. <xref ref-type="bibr" rid="CR45">2021</xref>). Despite the clinical and biological links between depression and cognitive decline in ageing, the potential contribution of depressive symptoms to the diagnostic workup of MCI and dementia caused by AD (AD dementia) has not been thoroughly studied yet. However, especially in light of forthcoming disease-modifying therapies for AD, it is of high relevance to explore whether depressive symptoms could contribute to the identification of individuals in the earliest stages of cognitive decline in order to screen people for biomarker testing and referral to specialist memory centres.</p><p id="Par3">The aim of this study was to explore the potential utility of depressive symptoms in distinguishing between cognitive impairment and healthy cognitive ageing in a Greek cohort using machine learning methods. Interestingly, machine learning models, being a type of artificial intelligence, are advanced probabilistic and statistical techniques which can easily, and correctly identify data patterns and have recently emerged as useful tools in clinical practice for instance in prediction of chronic diseases and mental health crises (Garriga et al.; Delpino et al. <xref ref-type="bibr" rid="CR11">2022</xref>). We hypothesized that (i) depressive symptoms can contribute to the detection of cognitive impairment, with a utility comparable to that of the widely used screening test Mini Mental State Examination (MMSE) (Arevalo-Rodriguez et al. <xref ref-type="bibr" rid="CR8">2021</xref>); (ii) a machine learning technique, considering depression scale items separately together with demographics, amplifies the utility of depressive symptoms in differentiating between cognitive impairment and healthy cognitive ageing.</p></sec><sec id="Sec2"><title>Materials and methods</title><p id="Par4">All study procedures were conducted in accordance with the ethical standards of the relevant national and institutional committees on human experimentation and with the Helsinki Declaration of 1975, as revised in 2008. They were approved by the &#x00395;thics and Research committees of the Eginition University Hospital (BEY846C8N2-32&#x003a0;, 24/18.02.2013; &#x003a9;&#x00396;5&#x00395;46&#x003a8;8&#x0039d;&#x00396;-7&#x003a4;4, 04/24.01.2018), the General University Hospital of Larissa (138/08.07.2009) and of the General University Hospital of Patras (535/07.10.2021). All participants or authorized representatives gave their written informed consent.</p><sec id="Sec3"><title>Participants</title><p id="Par5">The study sample included 277 older adults who underwent a comprehensive diagnostic workup for cognitive decline at the old age psychiatry outpatient clinics either at the Eginition University Hospital in Attica or at the Patras University General Hospital in the Region of Western Greece, and 1,936 participants of the Hellenic Epidemiological Longitudinal Investigation of Ageing and Diet (HELIAD) (Alexopoulos et al. <xref ref-type="bibr" rid="CR4">2021a</xref>; Vlachos et al. <xref ref-type="bibr" rid="CR50">2021</xref>). HELIAD recruited older adults from urban, suburban and rural sites, who were randomly sampled and invited to participate in the study. Baseline data were collected between 2011 and 2016. The study sample is a convenience one. Its participants went through a standardized comprehensive neuropsychiatric assessment that is typical for tertiary healthcare settings. Inclusion criteria were (1) age 65&#x000a0;years or older, (2) diagnosis of MCI or AD dementia, or absence of a neurocognitive disorder, (3) available 15- item Geriatric Depression Scale (GDS)- and MMSE data (Fountoulakis et al. <xref ref-type="bibr" rid="CR14">2000</xref>, <xref ref-type="bibr" rid="CR15">2014</xref>; Kourtesis et al. <xref ref-type="bibr" rid="CR26">2020</xref>). Diagnoses were established based on international criteria for MCI and AD dementia (Petersen <xref ref-type="bibr" rid="CR37">2004</xref>; Albert et al. <xref ref-type="bibr" rid="CR2">2011</xref>; McKhann et al. <xref ref-type="bibr" rid="CR32">2011</xref>; Sachdev et al. <xref ref-type="bibr" rid="CR40">2014</xref>). Individuals in whom cognitive deficits or functional impairment was not detected, were classified as cognitively healthy. The diagnoses were established through consensus meetings of all clinicians/investigators involved in the diagnostic workup of each individual.</p></sec><sec id="Sec4"><title>Assessment of depressive symptoms and cognitive function</title><p id="Par6">Depressive symptoms were captured with the 15-item GDS, a well-established, brief, self-report instrument for screening and evaluating depressive symptoms whose items require a yes/no response (Allgaier et al. <xref ref-type="bibr" rid="CR6">2011</xref>; Fountoulakis et al. <xref ref-type="bibr" rid="CR15">2014</xref>). Of note, the GDS does not include items related to the somatic symptoms of depression, which could be present in older individuals even in the absence of depression and subsequently embody a source of bias (Acosta Quiroz et al. <xref ref-type="bibr" rid="CR1">2021</xref>). The neurocognitive assessment included the MMSE (Fountoulakis et al. <xref ref-type="bibr" rid="CR14">2000</xref>; Creavin et al. <xref ref-type="bibr" rid="CR10">2016</xref>). It is a paper-and-pencil test, the administration of which does not exceed ten minutes. The MMSE has a maximum score of 30 points. It assesses orientation, learning, attention, memory, language and visual construction. According to a rule of thumb that is commonly employed in clinical practice, MMSE scores lower than 24 points indicate the presence of dementia, while scores ranging between 24 and 27 points are compatible with MCI (Fountoulakis et al. <xref ref-type="bibr" rid="CR14">2000</xref>; Zhang et al. <xref ref-type="bibr" rid="CR52">2021</xref>).</p></sec><sec id="Sec5"><title>Statistical and machine learning techniques-based analyses</title><p id="Par7">Differences across the three diagnostic groups were studied with Pearson Chi-squared (in case of nominal independent variables) and Kruskal Wallis Chi-squared test (in case of continuous variables), since the assumption of normality was violated based on Shapiro&#x02013;Wilk test. When a statistically significant difference was indicated based on Pearson&#x02019;s chi-squared test, post hoc multiple comparisons were conducted with Fisher's exact tests with p-value adjusted based on Bonferroni correction. In case of statistically significant differences based on Kruskal Wallis Chi-squared test Dunn's&#x000a0;post hoc tests&#x000a0;are carried out on each pair of groups and the adjusted p-values were obtained.</p><p id="Par8">Proportional odds logistic regression (POLR) models were employed in the entire study sample for studying the relationship between diagnostic groups (served as the ordinal dependent variable for the POLR models) and total GDS score, which is more commonly considered in clinical research and practice than GDS items separately, and MMSE, under consideration of age, sex, and education. For the sake of completeness, the POLR models considering GDS items separately were computed and their results are presented in the supplement. POLR models were employed, since MCI is an intermediate mental state between healthy cognitive ageing and dementia, particularly in clinical phenotypes caused by neurodegenerative disease such as AD (Albert et al. <xref ref-type="bibr" rid="CR2">2011</xref>; Vega and Newhouse <xref ref-type="bibr" rid="CR49">2014</xref>; Jongsiriyanyong and Limpawattana <xref ref-type="bibr" rid="CR24">2018</xref>; Alexopoulos et al. <xref ref-type="bibr" rid="CR5">2021b</xref>; Georgiou et al. <xref ref-type="bibr" rid="CR18">2023</xref>). Stratified repeated random subsampling (stratified bootstrap resampling) was used to recursive partitioning to training- and validation set (70/30 ratio) (James et al. <xref ref-type="bibr" rid="CR23">2005</xref>). The procedure was repeated 20,000 times and the results (parameters estimates over the training data sets and performance evaluation metrics over the training and the validation data sets) were then averaged over the splits. The machine learning technique, Adaptive Boosting classification algorithm (AdaBoost) was implemented in Python. AdaBoost uses the boosting technique as an Ensemble Method to improve the predictive power by converting several weak learners to strong learners (Zhu et al. <xref ref-type="bibr" rid="CR53">2009</xref>). It begins by fitting a classifier on the original dataset and then fits additional copies of the classifier on the same dataset but where the weights of incorrectly classified instances are adjusted such that subsequent classifiers focus more on cases in which they face difficulties in classifying them. The Synthetic Minority Oversampling Technique (SMOTE) was also applied to deal with the imbalanced datasets (Fern&#x000e1;ndez et al. <xref ref-type="bibr" rid="CR13">2018</xref>). AdaBoost was employed after proper scaling, i.e. standardizing the quantitative variables and encoding the qualitative variables, for exploring the utility of GDS items in distinguishing between cognitively healthy individuals and patients with MCI or AD dementia (Lu et al. <xref ref-type="bibr" rid="CR30">2015</xref>). GDS items were separately considered, since machine learning techniques can discover complex relationships and patterns in data (Sarker <xref ref-type="bibr" rid="CR41">2021</xref>). Nonetheless, for the sake of completeness, AdaBoost models considering GDS total score were also computed, and their results are presented in the supplement. The classification performance of the regression- and AdaBoost models including the GDS was also compared to the accuracy of classifying study participants using the MMSE total score and the MMSE score-based rule of thumb (Fountoulakis et al. <xref ref-type="bibr" rid="CR14">2000</xref>; Zhang et al. <xref ref-type="bibr" rid="CR52">2021</xref>). The utility of a diagnostic test in clinical practice cannot be exclusively justified through high accuracy values, but the sensitivity and specificity values should be balanced (Van Stralen et al. <xref ref-type="bibr" rid="CR48">2009</xref>). Additionally, for highly imbalanced data sets, the F1 Score, which combines sensitivity and precision&#x000a0;to one performance metric, is generally preferred from other metrics, such as the Area Under Curve (AUC), when there is a particular interest, as in this study, toward the classification of the minority class (see for example, (Gaudreault and Branco <xref ref-type="bibr" rid="CR17">2024</xref>)).</p></sec></sec><sec id="Sec6"><title>Results</title><p id="Par9">The study sample included <italic>n</italic>&#x02009;=&#x02009;1737 participants without cognitive impairment, <italic>n</italic>&#x02009;=&#x02009;334 with MCI, and <italic>n</italic>&#x02009;=&#x02009;142 with AD dementia. Sociodemographic and clinical data are shown in Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>. Age significantly differed across the diagnostic groups, with people with MCI or AD dementia being older compared to individuals without cognitive deficits. No significant differences in either education or sex distribution were detected. There were significant differences in GDS total scores between people with MCI or AD dementia and those without cognitive impairment, while the frequency of people with GDS scores indicating moderate to severe depression increased as cognitive impairment advanced (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>). People with MCI chose more often responses to twelve GDS items that point to the presence of depressive symptoms compared to participants without cognitive impairment and the difference between the groups was statistically significant. No differences were detected between these two groups in responses to the items related to worthlessness, loss of energy and suicidal thoughts. Statistically significant differences were observed between AD dementia and older individuals without cognitive deficits in responses to all GDS items except for the GDS item regarding &#x0201c;getting often bored&#x0201d; and the item pertaining to helplessness. Compared to people with MCI, older adults with AD dementia reported more frequently that they did not feel that it is wonderful to be alive and have feelings of hopelessness, worthlessness, memory difficulties. There was also a difference related to lack of energy between the two groups, but this difference did not reach statistical significance.<table-wrap id="Tab1"><label>Table&#x000a0;1</label><caption><p>Demographic and clinical data of the study sample</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left" rowspan="2">Individuals without cognitive impairment (Group 1, G1)</th><th align="left" rowspan="2">Individuals with Mild Cognitive Impairment (Group 2, G2)</th><th align="left" rowspan="2">Individuals with Dementia (Group 3, G3)</th><th align="left">Comparison of G1&#x02009;=&#x02009;G2&#x02009;=&#x02009;G3</th><th align="left" colspan="3">Pairwise Comparisons</th></tr><tr><th align="left"/><th align="left">Value of test statistic (p-value)</th><th align="left">G1&#x02013;G2</th><th align="left">G1&#x02013;G3</th><th align="left">G2&#x02013;G3</th></tr></thead><tbody><tr><td align="left">N</td><td align="left">1737</td><td align="left">334</td><td align="left">142</td><td align="left"/><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">Age, years*</td><td align="left">73.28 (5.24) [65,91]</td><td align="left">75.24 (5.49) [65,90]</td><td align="left">79.08 (5.98) [65,100]</td><td align="left">141.357<sup>&#x001c2;&#x001c2;</sup> (&#x0003c;&#x02009;0.001)</td><td align="left"><p>&#x02212;&#x000a0;233.342</p><p>&#x02009;&#x0003c;&#x02009;0.001<sup>&#x02021;&#x02021;</sup></p></td><td align="left"><p>&#x02212;&#x000a0;602.907</p><p>&#x02009;&#x0003c;&#x02009;0.001<sup>&#x02021;&#x02021;</sup></p></td><td align="left"><p>&#x02212;&#x000a0;369.565</p><p>&#x02009;&#x0003c;&#x02009;0.001<sup>&#x02021;&#x02021;</sup></p></td></tr><tr><td align="left">Sex (female, N, %)</td><td align="left">1059 (61.0)</td><td align="left">200 (59.9)</td><td align="left">78 (54.9)</td><td align="left">6.771<sup><bold>&#x001c2;</bold></sup> (0.034)</td><td align="left">1<sup>&#x02021;</sup></td><td align="left">0.471<sup>&#x02021;</sup></td><td align="left">0.948<sup>&#x02021;</sup></td></tr><tr><td align="left">Education, (&#x02264;&#x02009;9&#x000a0;years, %)</td><td align="left">1073 (61.8)</td><td align="left">224 (67.1)</td><td align="left">100 (70.4)</td><td align="left">2.048<sup><bold>&#x001c2;</bold></sup> (0.359)</td><td align="left"><p>3.309</p><p>0.220<sup>&#x02021;</sup></p></td><td align="left"><p>4.154</p><p>0.141<sup>&#x02021;</sup></p></td><td align="left"><p>0.516</p><p>1<sup>&#x02021;</sup></p></td></tr><tr><td align="left">Mini Mental State Examination (MMSE)</td><td align="left"><p>0.235 (0.674)</p><p>[&#x02212;&#x000a0;4.642,0.954]</p></td><td align="left"><p>&#x02212;&#x000a0;0.566 (0.946)</p><p>[&#x02212;&#x000a0;3.803, 0.954]</p></td><td align="left"><p>&#x02212;&#x000a0;2.243 (1.499)</p><p>[&#x02212;&#x000a0;6.041, 0.674]</p></td><td align="left">449.215<sup>&#x001c2;&#x001c2;</sup> (&#x0003c;&#x02009;0.001)</td><td align="left"><p>&#x02212;&#x000a0;517.137</p><p>&#x02009;&#x0003c;&#x02009;0.001<sup>&#x02021;&#x02021;</sup></p></td><td align="left"><p>&#x02212;&#x000a0;960.336</p><p>&#x02009;&#x0003c;&#x02009;0.001<sup>&#x02021;&#x02021;</sup></p></td><td align="left"><p>&#x02212;&#x000a0;443.199</p><p>&#x02009;&#x0003c;&#x02009;0.001<sup>&#x02021;&#x02021;</sup></p></td></tr><tr><td align="left">Geriatric depression scale (GDS) total score</td><td align="left">1.76 (2.68) [0,12]</td><td align="left">2.76 (3.22) [0,12]</td><td align="left">3.31 (3.78) [0,12]</td><td align="left">49.108<sup>&#x001c2;&#x001c2;</sup> (&#x0003c;&#x02009;0.001)</td><td align="left"><p>&#x02212;&#x000a0;194.610</p><p>&#x02009;&#x0003c;&#x02009;0.001<sup>&#x02021;&#x02021;</sup></p></td><td align="left"><p>&#x02212;&#x000a0;269.379</p><p>&#x02009;&#x0003c;&#x02009;0.001<sup>&#x02021;&#x02021;</sup></p></td><td align="left"><p>&#x02212;&#x000a0;74.768</p><p>&#x02009;&#x0003c;&#x02009;0.658<sup>&#x02021;&#x02021;</sup></p></td></tr><tr><td align="left">GDS total score indicating moderate to severe depression (GDS total score 9&#x02013;15) (N, %)</td><td align="left">60 (3.45)</td><td align="left">21 (6.29)</td><td align="left">20 (14.08)</td><td align="left">36.959<sup><bold>&#x001c2;</bold></sup> (&#x0003c;&#x02009;0.001)</td><td align="left"><p>6.360</p><p>0.006<sup>&#x02021;</sup></p></td><td align="left"><p>36.443</p><p>&#x02009;&#x0003c;&#x02009;0.001<sup>&#x02021;</sup></p></td><td align="left"><p>7.368</p><p>0.003<sup>&#x02021;</sup></p></td></tr><tr><td align="left">GDS Item 1 (depression positive, %)</td><td align="left">283 (16.3)</td><td align="left">77 (23.05)</td><td align="left">42 (29.6)</td><td align="left">21.909<sup>&#x001c2;</sup> (&#x0003c;&#x02009;0.001)</td><td align="left"><p>8.918</p><p>0.001<sup>&#x02021;</sup></p></td><td align="left"><p>16.196</p><p>&#x02009;&#x0003c;&#x02009;0.001<sup>&#x02021;</sup></p></td><td align="left"><p>2.262</p><p>0.404<sup>&#x02021;</sup></p></td></tr><tr><td align="left">GDS Item 2 (depression positive, %)</td><td align="left">419 (24.1)</td><td align="left">112 (33.5)</td><td align="left">62 (43.6)</td><td align="left">34.652<sup>&#x001c2;</sup> (&#x0003c;&#x02009;0.001)</td><td align="left"><p>13.013</p><p>&#x02009;&#x0003c;&#x02009;0.001<sup>&#x02021;</sup></p></td><td align="left"><p>26.315</p><p>&#x02009;&#x0003c;&#x02009;0.001<sup>&#x02021;</sup></p></td><td align="left"><p>4.408</p><p>0.114<sup>&#x02021;</sup></p></td></tr><tr><td align="left">GDS Item 3 (depression positive, %)</td><td align="left">293 (16.86)</td><td align="left">97 (29.04)</td><td align="left">43 (30.28)</td><td align="left">37.450<sup>&#x001c2;</sup> (&#x0003c;&#x02009;0.001)</td><td align="left"><p>27.161</p><p>&#x02009;&#x0003c;&#x02009;0.001<sup>&#x02021;</sup></p></td><td align="left"><p>16.084</p><p>&#x02009;&#x0003c;&#x02009;0.001<sup>&#x02021;</sup></p></td><td align="left"><p>0.074</p><p>1<sup>&#x02021;</sup></p></td></tr><tr><td align="left">GDS Item 4 (depression positive, %)</td><td align="left">346 (19.91)</td><td align="left">87 (26.05)</td><td align="left">37 (26.06)</td><td align="left">8.396<sup>&#x001c2;</sup> (0.015)</td><td align="left"><p>6.363</p><p>0.045<sup>&#x02021;</sup></p></td><td align="left"><p>3.046</p><p>0.251<sup>&#x02021;</sup></p></td><td align="left"><p>&#x02009;&#x0003c;&#x02009;0.001</p><p>1<sup>&#x02021;</sup></p></td></tr><tr><td align="left">GDS Item 5 (depression positive, %)</td><td align="left">365(21.01)</td><td align="left">113 (33.83)</td><td align="left">54 (38.03)</td><td align="left">41.469<sup>&#x001c2;</sup> (&#x0003c;&#x02009;0.001)</td><td align="left"><p>25.930</p><p>&#x02009;&#x0003c;&#x02009;0.001<sup>&#x02021;</sup></p></td><td align="left"><p>21.934</p><p>&#x02009;&#x0003c;&#x02009;0.001<sup>&#x02021;</sup></p></td><td align="left"><p>0.770</p><p>1<sup>&#x02021;</sup></p></td></tr><tr><td align="left">GDS Item 6 (depression positive, %)</td><td align="left">301 (17.32)</td><td align="left">92 (27.54)</td><td align="left">31 (21.83)</td><td align="left">19.576<sup>&#x001c2;</sup> (&#x0003c;&#x02009;0.001)</td><td align="left"><p>19.016</p><p>&#x02009;&#x0003c;&#x02009;0.001<sup>&#x02021;</sup></p></td><td align="left"><p>1.829</p><p>0.514<sup>&#x02021;</sup></p></td><td align="left"><p>1.698</p><p>0.628<sup>&#x02021;</sup></p></td></tr><tr><td align="left">GDS Item 7 (depression positive, %)</td><td align="left">332 (19.11)</td><td align="left">114 (34.13)</td><td align="left">47 (33.09)</td><td align="left">46.754<sup>&#x001c2;</sup> (&#x0003c;&#x02009;0.001)</td><td align="left"><p>37.392</p><p>&#x02009;&#x0003c;&#x02009;0.001<sup>&#x02021;</sup></p></td><td align="left"><p>15.945</p><p>&#x02009;&#x0003c;&#x02009;0.001<sup>&#x02021;</sup></p></td><td align="left"><p>0.048</p><p>1<sup>&#x02021;</sup></p></td></tr><tr><td align="left">GDS Item 8 (depression positive, %)</td><td align="left">210 (12.09)</td><td align="left">61 (18.26)</td><td align="left">23 (16.19)</td><td align="left">10.385<sup>&#x001c2;</sup> (0.006)</td><td align="left"><p>9.388</p><p>0.001<sup>&#x02021;</sup></p></td><td align="left"><p>2.039</p><p>0.516<sup>&#x02021;</sup></p></td><td align="left"><p>0.293</p><p>1<sup>&#x02021;</sup></p></td></tr><tr><td align="left">GDS Item 9 (depression positive, %)</td><td align="left">398 (22.9)</td><td align="left">110 (32.9)</td><td align="left">48 (33.8)</td><td align="left">21.029<sup>&#x001c2;</sup> (&#x0003c;&#x02009;0.001)</td><td align="left"><p>15.196</p><p>&#x02009;&#x0003c;&#x02009;0.001<sup>&#x02021;</sup></p></td><td align="left"><p>8.599</p><p>0.016<sup>&#x02021;</sup></p></td><td align="left"><p>0.034</p><p>1<sup>&#x02021;</sup></p></td></tr><tr><td align="left">GDS Item 10 (depression positive, %)</td><td align="left">135 (7.77)</td><td align="left">64 (19.16)</td><td align="left">46 (32.39)</td><td align="left">106.988<sup>&#x001c2;</sup> (&#x0003c;&#x02009;0.001)</td><td align="left"><p>41.840</p><p>&#x02009;&#x0003c;&#x02009;0.001<sup>&#x02021;</sup></p></td><td align="left"><p>91.423</p><p>&#x02009;&#x0003c;&#x02009;0.001<sup>&#x02021;</sup></p></td><td align="left"><p>9.819</p><p>0.008<sup>&#x02021;</sup></p></td></tr><tr><td align="left">GDS Item 11 (depression positive, %)</td><td align="left">92 (5.29)</td><td align="left">28 (8.38)</td><td align="left">24 (16.9)</td><td align="left"><bold>31.336</bold><sup><bold>&#x001c2;</bold></sup><bold> (&#x0003c;&#x02009;0.001)</bold></td><td align="left"><p><bold>4.890</bold></p><p><bold>0.112</bold><sup><bold>&#x02021;</bold></sup></p></td><td align="left"><p>30.520</p><p>&#x02009;&#x0003c;&#x02009;0.001<sup>&#x02021;</sup></p></td><td align="left"><p>7.430</p><p>0.028<sup>&#x02021;</sup></p></td></tr><tr><td align="left">GDS Item 12 (depression positive, %)</td><td align="left">105 (6.05)</td><td align="left">32 (9.58)</td><td align="left">29 (20.42)</td><td align="left"><bold>41.561</bold><sup><bold>&#x001c2;</bold></sup><bold> (&#x0003c;&#x02009;0.001)</bold></td><td align="left"><p><bold>5.670</bold></p><p><bold>0.066</bold><sup><bold>&#x02021;</bold></sup></p></td><td align="left"><p>40.972</p><p>&#x02009;&#x0003c;&#x02009;0.001<sup>&#x02021;</sup></p></td><td align="left"><p>10.482</p><p>0.007<sup>&#x02021;</sup></p></td></tr><tr><td align="left">GDS Item 13 (depression positive, %)</td><td align="left">304 (17.5)</td><td align="left">73 (21.85)</td><td align="left">47 (33.09)</td><td align="left">22.465<sup>&#x001c2;</sup> (&#x0003c;&#x02009;0.001)</td><td align="left"><p>3.568</p><p>0.189<sup>&#x02021;</sup></p></td><td align="left"><p>21.022</p><p>&#x02009;&#x0003c;&#x02009;0.001<sup>&#x02021;</sup></p></td><td align="left"><p>6.679</p><p>0.033<sup>&#x02021;</sup></p></td></tr><tr><td align="left">GDS Item 14 (depression positive, %)</td><td align="left">123 (7.08)</td><td align="left">50 (14.97)</td><td align="left">35 (24.65)</td><td align="left">61.906<sup>&#x001c2;</sup> (&#x0003c;&#x02009;0.001)</td><td align="left"><p>22.773</p><p>&#x02009;&#x0003c;&#x02009;0.001<sup>&#x02021;</sup></p></td><td align="left"><p>52.597</p><p>&#x02009;&#x0003c;&#x02009;0.001<sup>&#x02021;</sup></p></td><td align="left"><p><bold>6.362</bold></p><p><bold>0.040</bold><sup><bold>&#x02021;</bold></sup></p></td></tr><tr><td align="left">GDS Item 15 (depression positive, %)</td><td align="left">196 (11.28)</td><td align="left">59 (17.66)</td><td align="left">28 (19.71)</td><td align="left">16.761<sup>&#x001c2;</sup> (&#x0003c;&#x02009;0.001)</td><td align="left"><p>10.564</p><p>0.005<sup>&#x02021;</sup></p></td><td align="left"><p>8.894</p><p>0.014<sup>&#x02021;</sup></p></td><td align="left"><p>0.281</p><p>1<sup>&#x02021;</sup></p></td></tr></tbody></table><table-wrap-foot><p><sup>*</sup>Mean (standard deviation)[range]</p><p><sup>&#x001c2;&#x001c2;</sup>Kruskal&#x02013;Wallis test adjusted for ties</p><p><sup>&#x001c2;</sup>Pearson&#x02019;s chi-square</p><p><sup>&#x02021;&#x02021;</sup>Dunn&#x02019;s post hoc test p-value after Kruskal&#x02013;Wallis test</p><p><sup><bold>&#x02021;</bold></sup>Pearson&#x02019;s chi-square with Bonferroni adjusted p-value</p></table-wrap-foot></table-wrap></p><p id="Par10">Regression models, which were employed to investigate the relationship between cognitive diagnostic status and GDS total score and between cognitive diagnostic status and MMSE total score revealed that both GDS- and MMSE total scores were associated with the cognitive status of the participants (0.1322 [0.1092, 0.1547] and -0.4325 [-0.4653, -0.4920], respectively) (Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>). The accuracy of the POLR models including the GDS total scores as independent variable (training sets: 0.7850 [0.7824, 0.7875], validations sets: 0.7842 [0.7771, 0.7892]) was inferior to that of the POLR models including the MMSE (training sets: 0.8177 [0.8096, 0.8263], validation sets: 0.8170 [0.7997,08342]). Nonetheless, the difference in accuracy between them did not exceed 5% either in the training- or in the validation datasets (Table&#x000a0;<xref rid="Tab3" ref-type="table">3</xref>). The overall performance of the POLR models was acceptable (accuracy close to 0.8). However, the performance evaluation metrics of the model including GDS total score were very low both in detecting people without cognitive impairment (specificity) (training sets: 0.022 [0.0090, 0.0420], validation sets: 0.0214 [0.0000, 0.0420]) and in identifying older adults with MCI (sensitivity) (training sets: 0.0055 [0.0000, 0.0171], validation sets: 0.0053 [0.0000, 0.0200]) or AD dementia (training sets: 0.0412 [0.0202, 0.0606], validation sets: 0.0403 [0.0000, 0.0930]) and clearly lower than the respective specificity- and sensitivity values of the model including MMSE total score as independent variable (Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>). Of note, the utility of the regression model with GDS total scores as an independent variable, which is here presented, and of the model including responses to GDS items separately did not significantly differ (supplement, Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>S).<table-wrap id="Tab2"><label>Table&#x000a0;2</label><caption><p>The averages of the parameters of the proportional odds logistic regression model along with their 95% bootstrap confidence intervals based on 20,000 stratified bootstrap training sets</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left"/><th align="left">POLR with GDS as independent variable</th><th align="left">POLR with MMSE as independent variable</th></tr></thead><tbody><tr><td align="left">95% bootstrap confidence intervals</td><td align="left">Intercept 2|1*</td><td align="left">&#x02212;&#x000a0;9.3659 (&#x02212;&#x000a0;10.4006, &#x02212;&#x000a0;8.3737)</td><td align="left">7.8642 (6.2006, 9.5992)</td></tr><tr><td align="left"/><td align="left">Intercept 3|2*</td><td align="left">&#x02212;&#x000a0;10.8568 (&#x02212;&#x000a0;11.9115, &#x02212;&#x000a0;9.8472)</td><td align="left">5.6179 (3.9800, 7.3188)</td></tr><tr><td align="left">Covariates</td><td align="left">Age</td><td align="left">0.1059 (0.0935, 0.1188)</td><td align="left">0.0398 (0.0238, 0.0558)</td></tr><tr><td align="left"/><td align="left">Education</td><td align="left">0.1128 (&#x02212;&#x000a0;0.0332, 0.2631)</td><td align="left">&#x02212;&#x000a0;0.8582 (&#x02212;&#x000a0;1.0493, &#x02212;&#x000a0;0.6706)</td></tr><tr><td align="left"/><td align="left">Sex</td><td align="left">&#x02212;&#x000a0;0.1355 (&#x02212;&#x000a0;0.2872, 0.0140)</td><td align="left">&#x02212;&#x000a0;0.3033 (&#x02212;&#x000a0;0.4785, &#x02212;&#x000a0;0.1302)</td></tr><tr><td align="left"/><td align="left">Instrument</td><td align="left">0.1322 (0.1092, 0.1547)</td><td align="left">&#x02212;&#x000a0;0.4325 (&#x02212;&#x000a0;0.4653, &#x02212;&#x000a0;0.4029)</td></tr></tbody></table><table-wrap-foot><p>*Intercept <italic>j</italic>|(<italic>j</italic>&#x000a0;&#x02212;&#x000a0;1) denotes the intercept in <inline-formula id="IEq1"><alternatives><tex-math id="M1">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\log it(Y \ge j) = \log \left( {\frac{P(Y \ge j)}{{1 - P(Y \ge j)}}} \right)$$\end{document}</tex-math><mml:math id="M2"><mml:mrow><mml:mo>log</mml:mo><mml:mi>i</mml:mi><mml:mi>t</mml:mi><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>Y</mml:mi><mml:mo>&#x02265;</mml:mo><mml:mi>j</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:mo>log</mml:mo><mml:mfenced close=")" open="("><mml:mfrac><mml:mrow><mml:mi>P</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mi>Y</mml:mi><mml:mo>&#x02265;</mml:mo><mml:mi>j</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:mi>P</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mi>Y</mml:mi><mml:mo>&#x02265;</mml:mo><mml:mi>j</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mfrac></mml:mfenced></mml:mrow></mml:math><inline-graphic xlink:href="10433_2025_837_Article_IEq1.gif"/></alternatives></inline-formula> for Group <italic>j</italic>&#x02009;=&#x02009;2,3, where <italic>Y</italic> represents the response variable of the patient&#x02019;s diagnosis</p><p>GDS: 15-item Geriatric Depression Scale; MMSE: Mini Mental State Examination; POLR: Proportional odds logistic regression</p></table-wrap-foot></table-wrap><table-wrap id="Tab3"><label>Table&#x000a0;3</label><caption><p>The performance evaluation metrics for the two proportional odds logistic regression models along with their 95% bootstrap confidence intervals based on 20,000 stratified bootstrap training and validation sets</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2"/><th align="left" colspan="5">Training sets</th><th align="left" colspan="4">Validation sets</th></tr><tr><th align="left">Threshold</th><th align="left">Accuracy</th><th align="left">Sensitivity</th><th align="left">Specificity</th><th align="left">F1 score</th><th align="left">Accuracy</th><th align="left">Sensitivity</th><th align="left">Specificity</th><th align="left">F1 score</th></tr></thead><tbody><tr><td align="left">POLR with GDS as independent variable</td><td align="left"/><td align="left">0.7850 (0.7824, 0.7875)</td><td align="left">G1: 0.9957 (0.9918, 0.9984)</td><td align="left">G1: 0.0222 (0.0090, 0.0420)</td><td align="left">G1: 0.8798 (0.8784, 0.8814)</td><td align="left">0.7842 (0.7771, 0.7892)</td><td align="left">G1: 0.9953 (0.9866, 1.0000)</td><td align="left">G1: 0.0214 (0.0000, 0.0420)</td><td align="left">G1: 0.8792 (0.8753, 0.8823)</td></tr><tr><td align="left"/><td align="left"/><td align="left"/><td align="left">G2: 0.0055 (0.0000, 0.0171)</td><td align="left">G2: 0.9961 (0.9909, 0.9992)</td><td align="left">G2: 0.0145 (0.0082, 0.0328)</td><td align="left"/><td align="left">G2: 0.0053 (0.0000, 0.0200)</td><td align="left">G2: 0.9961 (0.9893, 1.0000)</td><td align="left">G2: 0.0247 (0.0187, 0.0561)</td></tr><tr><td align="left"/><td align="left"/><td align="left"/><td align="left">G3: 0.0412 (0.0202, 0.0606)</td><td align="left">G3: 0.9986 (0.9965, 1.0000)</td><td align="left">G3: 0.0773 (0.0385, 0.1132)</td><td align="left"/><td align="left">G3: 0.0403 (0.0000, 0.0930)</td><td align="left">G3: 0.9983 (0.9936, 1.0000)</td><td align="left">G3: 0.0854 (0.0426, 0.1702)</td></tr><tr><td align="left">POLR with MMSE as independent variable</td><td align="left"/><td align="left">0.8177 (0.8096, 0.8263)</td><td align="left">G1: 0.9679 (0.9635, 0.9725)</td><td align="left">G1: 0.3808 (0.3455, 0.4172)</td><td align="left">G1: 0.9098 (0.9050, 0.9149)</td><td align="left">0.8170 (0.7997, 0.8342)</td><td align="left">G1: 0.9677 (0.9522, 0.9831)</td><td align="left">G1: 0.3808 (0.3149, 0.4472)</td><td align="left">G1: 0.9095 (0.8995, 0.9193)</td></tr><tr><td align="left"/><td align="left"/><td align="left"/><td align="left">G2: 0.1768 (0.1408, 0.2140)</td><td align="left">G2: 0.9494 (0.9433, 0.9559)</td><td align="left">G2: 0.2412 (0.1974, 0.2848)</td><td align="left"/><td align="left">G2: 0.1744 (0.1099, 0.2444)</td><td align="left">G2: 0.9490 (0.9323, 0.9651)</td><td align="left">G2: 0.2372 (0.1565, 0.3172)</td></tr><tr><td align="left"/><td align="left"/><td align="left"/><td align="left">G3: 0.3949 (0.3375, 0.4512)</td><td align="left">G3: 0.9871 (0.9843, 0.9902)</td><td align="left">G3: 0.4890 (0.4286, 0.5469)</td><td align="left"/><td align="left">G3: 0.3935 (0.2500, 0.5429)</td><td align="left">G3: 0.9869 (0.9786, 0.9948)</td><td align="left">G3: 0.4855 (0.3461, 0.6182)</td></tr></tbody></table><table-wrap-foot><p>GDS: 15-item Geriatric Depression Scale; G1: Cognitively healthy individuals; G2: Mild cognitive impairment; G3: Dementia due to Alzheimer&#x02019;s disease LR: Logistic regression; MMSE: Mini Mental State Examination; POLR: Proportional odds logistic regression</p></table-wrap-foot></table-wrap></p><p id="Par11">The AdaBoost model yielded more balanced performance evaluation metrics compared to regression models (Table&#x000a0;<xref rid="Tab4" ref-type="table">4</xref>). Although the accuracy values of AdaBoost models were lower compared to the POLR models (AdaBoost model including GDS items: training sets 0.7292, validation sets: 0.7248; model including MMSE: training sets: 0.7259, validation sets: 0.6934) the sensitivity- and specificity values of both classifiers were more balanced resulting in higher F1 scores for the detection of MCI (model including GDS items: training sets: 0.6099, validation sets: 0.2935; model including MMSE: training sets: 0.5955, validation sets: 0.3754) and AD dementia (model including GDS items: training sets: 0.7661, validation sets: 0.2273; model including MMSE: training sets: 0.8278, validation sets: 0.5934) compared to the respective POLR models. The model with GDS items as independent variables had slightly higher average accuracy than the model with MMSE as independent variable, but specificity and sensitivity were more balanced in the latter model (Table&#x000a0;<xref rid="Tab4" ref-type="table">4</xref>). The metrics of AdaBoost models with GDS total scores as independent variable were slightly inferior to that of models considering responses to GDS items separately (supplement, Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>S).<table-wrap id="Tab4"><label>Table&#x000a0;4</label><caption><p>The performance evaluation metrics for the Adaptive Boosting algorithm (AdaBoost), which uses the boosting technique as an Ensemble Method, in the training and validation sets</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2"/><th align="left" colspan="4">Training sets</th><th align="left" colspan="4">Validation sets</th></tr><tr><th align="left">Accuracy</th><th align="left">Sensitivity</th><th align="left">Specificity</th><th align="left">F1 score</th><th align="left">Accuracy</th><th align="left">Sensitivity</th><th align="left">Specificity</th><th align="left">F1 score</th></tr></thead><tbody><tr><td align="left">AdaBoost with Smote with GDS Items as independent variables</td><td char="." align="char">0.7292</td><td align="left">G1: 0.8248</td><td align="left">G1: 0.8548</td><td align="left">G1: 0.7986</td><td char="." align="char">0.7248</td><td align="left">G1: 0.8429</td><td align="left">G1: 0.3189</td><td align="left">G1: 0.8480</td></tr><tr><td align="left"/><td char="." align="char"/><td align="left">G2: 0.5668</td><td align="left">G2: 0.8495</td><td align="left">G2: 0.6099</td><td char="." align="char"/><td align="left">G2: 0.3140</td><td align="left">G2: 0.8803</td><td align="left">G2: 0.2935</td></tr><tr><td align="left"/><td char="." align="char"/><td align="left">G3: 0.7937</td><td align="left">G3: 0.8250</td><td align="left">G3: 0.7661</td><td char="." align="char"/><td align="left">G3: 0.2128</td><td align="left">G3: 0.9241</td><td align="left">G3: 0.2273</td></tr><tr><td align="left">AdaBoost with Smote with MMSE as independent variable</td><td char="." align="char">0.7259</td><td align="left">G1: 0.7224</td><td align="left">G1: 0.8755</td><td align="left">G1: 0.7471</td><td char="." align="char">0.6934</td><td align="left">G1: 0.7223</td><td align="left">G1: 0.7193</td><td align="left">G1: 0.8086</td></tr><tr><td align="left"/><td char="." align="char"/><td align="left">G2: 0.5971</td><td align="left">G2: 0.7988</td><td align="left">G2: 0.5955</td><td char="." align="char"/><td align="left">G2: 0.5612</td><td align="left">G2: 0.7338</td><td align="left">G2: 0.3754</td></tr><tr><td align="left"/><td char="." align="char"/><td align="left">G3: 0.8517</td><td align="left">G3: 0.8591</td><td align="left">G3: 0.8278</td><td char="." align="char"/><td align="left">G3: 0.6585</td><td align="left">G3: 0.9474</td><td align="left">G3: 0.5934</td></tr></tbody></table><table-wrap-foot><p>GDS: 15-item Geriatric Depression Scale; G1: Cognitively healthy individuals; G2: Mild cognitive impairment; G3: Dementia due to Alzheimer&#x02019;s disease; MMSE: Mini Mental State Examination</p></table-wrap-foot></table-wrap></p><p id="Par12">The classification accuracy of the regression- and AdaBoost models with MMSE or depressive symptoms as independent variables was higher than that of the rule of thumb commonly used for classifying the cognitive function of individuals based on their performance on the MMSE in clinical practice. More specifically, the accuracy of this rule of thumb was 58.41%. The sensitivity and specificity in detecting MCI was 44.70% and 67.44%, respectively and in identifying AD dementia was 84.07% and 88.58%, respectively.</p></sec><sec id="Sec7"><title>Discussion</title><p id="Par13">The present study sheds light on the potential utility of commonly detected depressive symptoms in contributing to the identification of MCI and AD dementia in older adults. The study and its findings expand previous literature as they (i) show that despite imbalances in performance evaluation metrics, the GDS tends to have a classification accuracy comparable to that of the widely used cognitive screening test MMSE particularly when machine learning techniques are employed, (ii) apply the AdaBoost machine learning technique, and (iii) consider each depression scale item separately in addition to the conventional strategy of considering depression scale total scores.</p><p id="Par14">The findings yielded by the AdaBoost models showed that GDS items can differentiate between cognitively healthy ageing and both MCI and AD dementia with an accuracy similar to that of MMSE total score and superior to the MMSE score-based rule of thumb commonly used in clinical practice. Considering that the MMSE is one of the most widely used cognitive screening tests among older people, these results point to the potential utility of the GDS for identifying older individuals with possible cognitive impairment. Compared to the MMSE, which needs to be administered by trained staff, the GDS can be administered within approximately five minutes, even in the waiting room of a medical facility with minimal support of nonmedical staff (Costa et al. <xref ref-type="bibr" rid="CR9">2016</xref>); as such it could be easily used as a quick and rough screening tool in GP practices and primary healthcare centres. Provided the observations of our study are replicated in independent cohorts and balanced evaluation metrics are found, classification tools relying on machine learning techniques and GDS items may become in the future a low-cost, time efficient approach to identify cognitive impairment in ageing in community settings.</p><p id="Par15">Compared to the regression models, the boosting technique using an Ensemble Method showed in most cases more balanced classification performance, as indicated by F1- values (Ndichu et al. <xref ref-type="bibr" rid="CR33">2023</xref>), albeit with lower accuracy values. F1 is a better metric to assess the quality of classification models when the classes are imbalanced and there is a serious downside to predicting false negatives values, since a model tends to be biased towards majority class samples (Ndichu et al. <xref ref-type="bibr" rid="CR33">2023</xref>). The disproportionate classification values in POLR models may also be partially attributed to the diagnostic uncertainties related to the distinguishment between MCI and dementia in clinical practice (Knopman and Petersen <xref ref-type="bibr" rid="CR25">2014</xref>; Lee <xref ref-type="bibr" rid="CR28">2023</xref>). The more balanced classification performance of AdaBoost models may be attributed to the fact that traditional classification models like regression models tend to ignore the imbalanced data issue, leading to poor classification performance in imbalanced datasets (Shahri et al. <xref ref-type="bibr" rid="CR43">2021</xref>). Moreover, AdaBoost models can make predictions through discovering generalizable nonlinear latent patterns between variables.</p><p id="Par16">Depressive symptoms significantly differed between the diagnostic groups with higher GDS total scores among individuals with cognitive impairment. These observations are in line with consistent evidence pointing to higher frequency of depressive symptoms in people with MCI and AD dementia (Ismail et al. <xref ref-type="bibr" rid="CR22">2017</xref>; Leung et al. <xref ref-type="bibr" rid="CR29">2021</xref>). Although the statistically significant differences in responses to GDS items between individuals without cognitive impairment and older adults with MCI or AD dementia were related to affective (e.g. pessimism, loss of interest), cognitive (e.g. worthlessness, dislike of self), and somatic symptoms (e.g. loss of energy, concentration difficulties) (O&#x02019;Shea et al. <xref ref-type="bibr" rid="CR36">2018</xref>), the symptoms that differed between MCI and AD dementia were mainly cognitive and somatic and not affective. This observation is in accordance with previous studies pointing out that progression of cognitive impairment is accompanied by physical activity decline and loss of self-esteem (Hu et al. <xref ref-type="bibr" rid="CR21">2016</xref>; Scott <xref ref-type="bibr" rid="CR42">2022</xref>), while sadness may not be the most prominent depressive symptom in people with dementia (Helvik et al. <xref ref-type="bibr" rid="CR20">2019</xref>). The observed complex patterns of variation of responses to the different scale items across the study groups underscore the necessity of employing analytical methods able to discover complex relationships between items and devoted to maximizing classification performance. Furthermore, they illustrate that the exclusive focus on depression severity may deprive the input of individual depressive symptoms in distinguishing between healthy cognitive ageing and cognitive impairment of valuable information.</p><p id="Par17">Depressive symptoms and other neuropsychiatric symptoms (e.g. anxiety, apathy, delusions, and hallucinations) are a group of symptoms of the phenotype of both MCI and dementia. They affect up to 90% of people with dementia over the course of the syndrome, while they are present in 35&#x02013;85% of individuals with MCI (Martin and Velayudhan <xref ref-type="bibr" rid="CR31">2020</xref>; Lagan&#x000e0; et al. <xref ref-type="bibr" rid="CR27">2022</xref>; Saari <xref ref-type="bibr" rid="CR39">2022</xref>). Interestingly, neuropsychiatric symptoms have been shown to be related to AD biomarkers (Ng et al. <xref ref-type="bibr" rid="CR34">2021</xref>; Spampinato et al. <xref ref-type="bibr" rid="CR46">2023</xref>) and the total score of the Neuropsychiatric Inventory Questionnaire (NPI-Q) has been recently found to pertain to staging of cognitive impairment in ageing ((Gonz&#x000e1;lez et al. <xref ref-type="bibr" rid="CR19">2024</xref>)). Nonetheless, their potential contribution to detecting and diagnosing MCI and dementia has not been thoroughly studied yet (And et al. <xref ref-type="bibr" rid="CR7">2022</xref>). Despite the detected imbalances in performance evaluation metrics, our observations yield first evidence of the potential utility of depressive symptoms in the diagnostic workup of neurocognitive disorders.</p><p id="Par18">This study has several limitations. First, depressive symptoms were captured with the GDS, a valid and reliable instrument, which, however, may have led to an overestimation of the presence of depressive symptoms (Thombs et al. <xref ref-type="bibr" rid="CR47">2018</xref>; Shin et al. <xref ref-type="bibr" rid="CR44">2019</xref>). Another limitation is that although the frequency of cognitive impairment was in line with previous reports (Nichols et al. <xref ref-type="bibr" rid="CR35">2022</xref>), the study sample was imbalanced with regard to people with MCI or AD dementia and those without cognitive impairment. To address this imbalance, the cohort was expanded beyond participants of HELIAD. Additional individuals evaluated at two old age psychiatry university outpatient clinics were included to enrich the sample. Furthermore, psychotropic medication (e.g. antidepressants, cholinesterase inhibitors) was not considered in the analyses, since GDS items are treated here as a pragmatic, simple tool to triage trajectories of cognitive decline in ageing screening tool that can be administered with minimal support of nonmedical staff. The diagnostic workup of the study sample is based on an extensive diagnostic workup which is not compatible with community-based healthcare. Thus, the utility of GDS items as an easy and quick screening tool warrants investigation in community settings, since the administration of the GDS precisely in such settings could be of great value in giving guidance to general practitioners for the necessity of further diagnostic steps. Finally, the clinical diagnoses of dementia and MCI were based on international diagnostic criteria. Nevertheless, the clinical diagnoses are neither always confirmed at autopsy nor always supported by biomarker constellations typical for AD (Georgiou et al. <xref ref-type="bibr" rid="CR18">2023</xref>). Thus, possibly erroneous clinical assessments should be also taken into account.</p><p id="Par19">The findings of the study provide initial evidence that depressive symptoms may contribute to distinguishing between cognitive impairment and cognitively healthy ageing. Since depressive symptoms can be easily captured through brief depression scales in primary care clinical settings, they may contribute to directing older patients with cognitive complaints to targeted diagnostic pathways, especially in the dawn of disease-modifying treatments and in the absence of established non-invasive and affordable biomarkers. Nonetheless, the detected imbalances in performance evaluation metrics point out that the clinical usefulness of GDS items in detecting cognitive impairment should be treated with caution. Before final conclusions can be drawn, further studies using behavioural instruments other than the GDS, considering non- AD dementias and/or including AD biomarkers are needed in order to shed light on the potential clinical utility of such findings.</p></sec><sec id="Sec8" sec-type="supplementary-material"><title>Supplementary Information</title><p>Below is the link to the electronic supplementary material.<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="10433_2025_837_MOESM1_ESM.docx"><caption><p>Supplementary file1 (DOCX 18 KB)</p></caption></media></supplementary-material></p></sec></body><back><fn-group><fn><p><bold>Publisher's Note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><ack><title>Acknowledgements</title><p>This research received no specific grant from any funding agency, commercial or not-for-profit sectors. The publication of the article in OA mode was financially supported by HEAL-Link.</p></ack><notes notes-type="author-contribution"><title>Author contributions</title><p>The study design was conceptualized PA. PA, NS, AB, PE contributed to methodology. PA, EK, KS, MS, EZ, MC, AP, MHK, MY, ED, GH, PS, NS participated in the investigation. PE, CB, AB conducted the statistical analyses. All authors contributed to the interpretation of the findings. PA wrote the first draft of the manuscript, which was critically revised by all authors. All authors agreed on the final version and to submit the present manuscript.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>This research received no specific grant from any funding agency, commercial or not-for-profit sectors. The publication of the article in OA mode was financially supported by HEAL-Link.</p></notes><notes notes-type="data-availability"><title>Availability of data and materials</title><p>The dataset used and analysed during the current study is available from the corresponding author on reasonable request.</p></notes><notes><title>Declarations</title><notes id="FPar1" notes-type="COI-statement"><title>Competing interests</title><p id="Par20">The authors declare no competing interests.</p></notes></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><citation-alternatives><element-citation id="ec-CR1" publication-type="journal"><person-group person-group-type="author"><name><surname>Acosta Quiroz</surname><given-names>CO</given-names></name><name><surname>Garc&#x000ed;a-Flores</surname><given-names>R</given-names></name><name><surname>Echeverr&#x000ed;a-Castro</surname><given-names>SB</given-names></name></person-group><article-title>The geriatric depression scale (GDS-15): validation in Mexico and disorder in the state of knowledge</article-title><source>Int J Aging Hum Dev</source><year>2021</year><volume>93</volume><fpage>854</fpage><pub-id pub-id-type="doi">10.1177/0091415020957387</pub-id><pub-id pub-id-type="pmid">32960071</pub-id>
</element-citation><mixed-citation id="mc-CR1" publication-type="journal">Acosta Quiroz CO, Garc&#x000ed;a-Flores R, Echeverr&#x000ed;a-Castro SB (2021) The geriatric depression scale (GDS-15): validation in Mexico and disorder in the state of knowledge. Int J Aging Hum Dev 93:854. 10.1177/0091415020957387<pub-id pub-id-type="pmid">32960071</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR2"><citation-alternatives><element-citation id="ec-CR2" publication-type="journal"><person-group person-group-type="author"><name><surname>Albert</surname><given-names>MS</given-names></name><name><surname>DeKosky</surname><given-names>ST</given-names></name><name><surname>Dickson</surname><given-names>D</given-names></name><etal/></person-group><article-title>The diagnosis of mild cognitive impairment due to Alzheimer&#x02019;s disease: recommendations from the National Institute on Aging-Alzheimer&#x02019;s Association workgroups on diagnostic guidelines for Alzheimer&#x02019;s disease</article-title><source>Alzheimers Dement</source><year>2011</year><volume>7</volume><fpage>270</fpage><lpage>279</lpage><pub-id pub-id-type="doi">10.1016/J.JALZ.2011.03.008</pub-id><pub-id pub-id-type="pmid">21514249</pub-id>
</element-citation><mixed-citation id="mc-CR2" publication-type="journal">Albert MS, DeKosky ST, Dickson D et al (2011) The diagnosis of mild cognitive impairment due to Alzheimer&#x02019;s disease: recommendations from the National Institute on Aging-Alzheimer&#x02019;s Association workgroups on diagnostic guidelines for Alzheimer&#x02019;s disease. Alzheimers Dement 7:270&#x02013;279. 10.1016/J.JALZ.2011.03.008<pub-id pub-id-type="pmid">21514249</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR3"><citation-alternatives><element-citation id="ec-CR3" publication-type="journal"><person-group person-group-type="author"><name><surname>Alexopoulos</surname><given-names>GS</given-names></name></person-group><article-title>Mechanisms and treatment of late-life depression</article-title><source>Transl Psychiatry</source><year>2019</year><pub-id pub-id-type="doi">10.1038/S41398-019-0514-6</pub-id></element-citation><mixed-citation id="mc-CR3" publication-type="journal">Alexopoulos GS (2019) Mechanisms and treatment of late-life depression. Transl Psychiatry. 10.1038/S41398-019-0514-6</mixed-citation></citation-alternatives></ref><ref id="CR4"><citation-alternatives><element-citation id="ec-CR4" publication-type="journal"><person-group person-group-type="author"><name><surname>Alexopoulos</surname><given-names>P</given-names></name><name><surname>Skondra</surname><given-names>M</given-names></name><name><surname>Kontogianni</surname><given-names>E</given-names></name><etal/></person-group><article-title>Validation of the cognitive telephone screening instruments COGTEL and COGTEL+ in identifying clinically diagnosed neurocognitive disorder due to Alzheimer&#x02019;s disease in a naturalistic clinical setting</article-title><source>J Alzheimer&#x02019;s Dis</source><year>2021</year><pub-id pub-id-type="doi">10.3233/JAD-210477</pub-id></element-citation><mixed-citation id="mc-CR4" publication-type="journal">Alexopoulos P, Skondra M, Kontogianni E et al (2021a) Validation of the cognitive telephone screening instruments COGTEL and COGTEL+ in identifying clinically diagnosed neurocognitive disorder due to Alzheimer&#x02019;s disease in a naturalistic clinical setting. J Alzheimer&#x02019;s Dis. 10.3233/JAD-210477</mixed-citation></citation-alternatives></ref><ref id="CR5"><mixed-citation publication-type="other">Alexopoulos P, Skondra M, Kontogianni E, et al (2021b) Validation of the Cognitive Telephone Screening Instruments COGTEL and COGTEL+ in Identifying Clinically Diagnosed Neurocognitive Disorder Due to Alzheimer&#x02019;s Disease in a Naturalistic Clinical Setting the Creative Commons Attribution-NonCommercial License (CC BY-NC 4.0). 260 P. Alexopoulos et al. / COGTEL+ in Neurocognitive Disorder Detection. Journal of Alzheimer&#x02019;s Disease 83:259&#x02013;268. 10.3233/JAD-210477</mixed-citation></ref><ref id="CR6"><citation-alternatives><element-citation id="ec-CR6" publication-type="journal"><person-group person-group-type="author"><name><surname>Allgaier</surname><given-names>AK</given-names></name><name><surname>Kramer</surname><given-names>D</given-names></name><name><surname>Mergl</surname><given-names>R</given-names></name><etal/></person-group><article-title>Validit&#x000e4;t der geriatrischen depressionsskala bei altenheimbewohnern: vergleich von GDS-15, GDS-8 und GDS-4</article-title><source>Psychiatr Prax</source><year>2011</year><volume>38</volume><fpage>280</fpage><lpage>286</lpage><pub-id pub-id-type="doi">10.1055/S-0030-1266105/ID/35</pub-id><pub-id pub-id-type="pmid">21598210</pub-id>
</element-citation><mixed-citation id="mc-CR6" publication-type="journal">Allgaier AK, Kramer D, Mergl R et al (2011) Validit&#x000e4;t der geriatrischen depressionsskala bei altenheimbewohnern: vergleich von GDS-15, GDS-8 und GDS-4. Psychiatr Prax 38:280&#x02013;286. 10.1055/S-0030-1266105/ID/35<pub-id pub-id-type="pmid">21598210</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR7"><citation-alternatives><element-citation id="ec-CR7" publication-type="journal"><person-group person-group-type="author"><name><surname>And</surname><given-names>N</given-names></name><name><surname>Neurology</surname><given-names>B</given-names></name><name><surname>Clos</surname><given-names>S</given-names></name><name><surname>Chabrashvili</surname><given-names>T</given-names></name></person-group><article-title>The use of neuropsychiatric symptoms as biomarkers for a prodromal state among an electronic medical record cohort of neurodegenerative disorders</article-title><source>Alzheimer&#x02019;s Dementia</source><year>2022</year><volume>18</volume><fpage>e066412</fpage><pub-id pub-id-type="doi">10.1002/ALZ.066412</pub-id></element-citation><mixed-citation id="mc-CR7" publication-type="journal">And N, Neurology B, Clos S, Chabrashvili T (2022) The use of neuropsychiatric symptoms as biomarkers for a prodromal state among an electronic medical record cohort of neurodegenerative disorders. Alzheimer&#x02019;s Dementia 18:e066412. 10.1002/ALZ.066412</mixed-citation></citation-alternatives></ref><ref id="CR8"><citation-alternatives><element-citation id="ec-CR8" publication-type="journal"><person-group person-group-type="author"><name><surname>Arevalo-Rodriguez</surname><given-names>I</given-names></name><name><surname>Smailagic</surname><given-names>N</given-names></name><name><surname>Roqu&#x000e9;-Figuls</surname><given-names>M</given-names></name><etal/></person-group><article-title>Mini-Mental State Examination (MMSE) for the early detection of dementia in people with mild cognitive impairment (MCI)</article-title><source>Cochrane Database Syst Rev</source><year>2021</year><pub-id pub-id-type="doi">10.1002/14651858.CD010783.PUB3</pub-id></element-citation><mixed-citation id="mc-CR8" publication-type="journal">Arevalo-Rodriguez I, Smailagic N, Roqu&#x000e9;-Figuls M et al (2021) Mini-Mental State Examination (MMSE) for the early detection of dementia in people with mild cognitive impairment (MCI). Cochrane Database Syst Rev. 10.1002/14651858.CD010783.PUB3</mixed-citation></citation-alternatives></ref><ref id="CR9"><citation-alternatives><element-citation id="ec-CR9" publication-type="journal"><person-group person-group-type="author"><name><surname>Costa</surname><given-names>MV</given-names></name><name><surname>Diniz</surname><given-names>MF</given-names></name><name><surname>Nascimento</surname><given-names>KK</given-names></name><etal/></person-group><article-title>Accuracy of three depression screening scales to diagnose major depressive episodes in older adults without neurocognitive disorders</article-title><source>Braz J Psychiatry</source><year>2016</year><volume>38</volume><fpage>154</fpage><lpage>156</lpage><pub-id pub-id-type="doi">10.1590/1516-4446-2015-1818</pub-id><pub-id pub-id-type="pmid">27304758</pub-id>
</element-citation><mixed-citation id="mc-CR9" publication-type="journal">Costa MV, Diniz MF, Nascimento KK et al (2016) Accuracy of three depression screening scales to diagnose major depressive episodes in older adults without neurocognitive disorders. Braz J Psychiatry 38:154&#x02013;156. 10.1590/1516-4446-2015-1818<pub-id pub-id-type="pmid">27304758</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR10"><citation-alternatives><element-citation id="ec-CR10" publication-type="journal"><person-group person-group-type="author"><name><surname>Creavin</surname><given-names>ST</given-names></name><name><surname>Wisniewski</surname><given-names>S</given-names></name><name><surname>Noel-Storr</surname><given-names>AH</given-names></name><etal/></person-group><article-title>Mini-Mental State Examination (MMSE) for the detection of dementia in clinically unevaluated people aged 65 and over in community and primary care populations</article-title><source>Cochrane Database System Rev</source><year>2016</year><pub-id pub-id-type="doi">10.1002/14651858.CD011145.PUB2</pub-id></element-citation><mixed-citation id="mc-CR10" publication-type="journal">Creavin ST, Wisniewski S, Noel-Storr AH et al (2016) Mini-Mental State Examination (MMSE) for the detection of dementia in clinically unevaluated people aged 65 and over in community and primary care populations. Cochrane Database System Rev. 10.1002/14651858.CD011145.PUB2</mixed-citation></citation-alternatives></ref><ref id="CR11"><citation-alternatives><element-citation id="ec-CR11" publication-type="journal"><person-group person-group-type="author"><name><surname>Delpino</surname><given-names>FM</given-names></name><name><surname>Costa</surname><given-names>K</given-names></name><name><surname>Farias</surname><given-names>SR</given-names></name><etal/></person-group><article-title>Machine learning for predicting chronic diseases: a systematic review</article-title><source>Public Health</source><year>2022</year><volume>205</volume><fpage>14</fpage><lpage>25</lpage><pub-id pub-id-type="doi">10.1016/J.PUHE.2022.01.007</pub-id><pub-id pub-id-type="pmid">35219838</pub-id>
</element-citation><mixed-citation id="mc-CR11" publication-type="journal">Delpino FM, Costa K, Farias SR et al (2022) Machine learning for predicting chronic diseases: a systematic review. Public Health 205:14&#x02013;25. 10.1016/J.PUHE.2022.01.007<pub-id pub-id-type="pmid">35219838</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR12"><citation-alternatives><element-citation id="ec-CR12" publication-type="journal"><person-group person-group-type="author"><name><surname>Eliza Georgiou</surname><given-names>E-Z</given-names></name><name><surname>Politis</surname><given-names>A</given-names></name><name><surname>Kosmidis</surname><given-names>MH</given-names></name><etal/></person-group><article-title>Depressive symptoms in the entire spectrum of cognitive ageing in Greece: evidence from the Hellenic Longitudinal Investigation of Aging and Diet (HELIAD)</article-title><source>Int J Psychiatry Clin Pract</source><year>2023</year><pub-id pub-id-type="doi">10.1080/13651501.2023.2296889</pub-id></element-citation><mixed-citation id="mc-CR12" publication-type="journal">Eliza Georgiou E-Z, Politis A, Kosmidis MH et al (2023) Depressive symptoms in the entire spectrum of cognitive ageing in Greece: evidence from the Hellenic Longitudinal Investigation of Aging and Diet (HELIAD). Int J Psychiatry Clin Pract. 10.1080/13651501.2023.2296889</mixed-citation></citation-alternatives></ref><ref id="CR13"><citation-alternatives><element-citation id="ec-CR13" publication-type="journal"><person-group person-group-type="author"><name><surname>Fern&#x000e1;ndez</surname><given-names>A</given-names></name><name><surname>Garc&#x000ed;a</surname><given-names>S</given-names></name><name><surname>Herrera</surname><given-names>F</given-names></name><name><surname>Chawla</surname><given-names>NV</given-names></name></person-group><article-title>SMOTE for learning from imbalanced data: progress and challenges, marking the 15-year anniversary</article-title><source>J Artif Intell Res</source><year>2018</year><volume>61</volume><fpage>863</fpage><lpage>905</lpage><pub-id pub-id-type="doi">10.1613/JAIR.1.11192</pub-id></element-citation><mixed-citation id="mc-CR13" publication-type="journal">Fern&#x000e1;ndez A, Garc&#x000ed;a S, Herrera F, Chawla NV (2018) SMOTE for learning from imbalanced data: progress and challenges, marking the 15-year anniversary. J Artif Intell Res 61:863&#x02013;905. 10.1613/JAIR.1.11192</mixed-citation></citation-alternatives></ref><ref id="CR14"><citation-alternatives><element-citation id="ec-CR14" publication-type="journal"><person-group person-group-type="author"><name><surname>Fountoulakis</surname><given-names>KN</given-names></name><name><surname>Tsolaki</surname><given-names>M</given-names></name><name><surname>Chantzi</surname><given-names>H</given-names></name><name><surname>Kazis</surname><given-names>A</given-names></name></person-group><article-title>Mini Mental State Examination (MMSE): a validation study in Greece</article-title><source>Am J Alzheimers Dis Other Demen</source><year>2000</year><volume>15</volume><fpage>342</fpage><lpage>345</lpage><pub-id pub-id-type="doi">10.1177/153331750001500604</pub-id></element-citation><mixed-citation id="mc-CR14" publication-type="journal">Fountoulakis KN, Tsolaki M, Chantzi H, Kazis A (2000) Mini Mental State Examination (MMSE): a validation study in Greece. Am J Alzheimers Dis Other Demen 15:342&#x02013;345. 10.1177/153331750001500604</mixed-citation></citation-alternatives></ref><ref id="CR15"><citation-alternatives><element-citation id="ec-CR15" publication-type="journal"><person-group person-group-type="author"><name><surname>Fountoulakis</surname><given-names>KN</given-names></name><name><surname>Tsolaki</surname><given-names>M</given-names></name><name><surname>Iacovides</surname><given-names>A</given-names></name><etal/></person-group><article-title>The validation of the short form of the Geriatric Depression Scale (GDS) in Greece</article-title><source>Aging Clin Exp Res</source><year>2014</year><volume>11</volume><fpage>367</fpage><lpage>372</lpage><pub-id pub-id-type="doi">10.1007/BF03339814</pub-id></element-citation><mixed-citation id="mc-CR15" publication-type="journal">Fountoulakis KN, Tsolaki M, Iacovides A et al (2014) The validation of the short form of the Geriatric Depression Scale (GDS) in Greece. Aging Clin Exp Res 11:367&#x02013;372. 10.1007/BF03339814</mixed-citation></citation-alternatives></ref><ref id="CR16"><mixed-citation publication-type="other">Garriga R, Mas J, Abraha S, et al Machine learning model to predict mental health crises from electronic health records. 10.1038/s41591-022-01811-5</mixed-citation></ref><ref id="CR17"><citation-alternatives><element-citation id="ec-CR17" publication-type="journal"><person-group person-group-type="author"><name><surname>Gaudreault</surname><given-names>JG</given-names></name><name><surname>Branco</surname><given-names>P</given-names></name></person-group><article-title>Empirical analysis of performance assessment for imbalanced classification</article-title><source>Mach Learn</source><year>2024</year><volume>113</volume><fpage>5533</fpage><lpage>5575</lpage><pub-id pub-id-type="doi">10.1007/S10994-023-06497-5</pub-id></element-citation><mixed-citation id="mc-CR17" publication-type="journal">Gaudreault JG, Branco P (2024) Empirical analysis of performance assessment for imbalanced classification. Mach Learn 113:5533&#x02013;5575. 10.1007/S10994-023-06497-5</mixed-citation></citation-alternatives></ref><ref id="CR18"><citation-alternatives><element-citation id="ec-CR18" publication-type="journal"><person-group person-group-type="author"><name><surname>Georgiou</surname><given-names>EZ</given-names></name><name><surname>Skondra</surname><given-names>M</given-names></name><name><surname>Charalampopoulou</surname><given-names>M</given-names></name><etal/></person-group><article-title>Validation of the test for finding word retrieval deficits (WoFi) in detecting Alzheimer&#x02019;s disease in a naturalistic clinical setting</article-title><source>Eur J Ageing</source><year>2023</year><volume>20</volume><fpage>15</fpage><pub-id pub-id-type="doi">10.1007/S10433-023-00772-Z</pub-id><pub-id pub-id-type="pmid">37166574</pub-id>
</element-citation><mixed-citation id="mc-CR18" publication-type="journal">Georgiou EZ, Skondra M, Charalampopoulou M et al (2023) Validation of the test for finding word retrieval deficits (WoFi) in detecting Alzheimer&#x02019;s disease in a naturalistic clinical setting. Eur J Ageing 20:15. 10.1007/S10433-023-00772-Z<pub-id pub-id-type="pmid">37166574</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR19"><citation-alternatives><element-citation id="ec-CR19" publication-type="journal"><person-group person-group-type="author"><name><surname>Gonz&#x000e1;lez</surname><given-names>DA</given-names></name><name><surname>Finley</surname><given-names>JCA</given-names></name><name><surname>Patel</surname><given-names>SES</given-names></name><name><surname>Soble</surname><given-names>JR</given-names></name></person-group><article-title>Practical assessment of neuropsychiatric symptoms: updated reliability, validity, and cutoffs for the neuropsychiatric inventory questionnaire</article-title><source>Am J Geriatric Psychiatry</source><year>2024</year><pub-id pub-id-type="doi">10.1016/j.jagp.2024.10.014</pub-id></element-citation><mixed-citation id="mc-CR19" publication-type="journal">Gonz&#x000e1;lez DA, Finley JCA, Patel SES, Soble JR (2024) Practical assessment of neuropsychiatric symptoms: updated reliability, validity, and cutoffs for the neuropsychiatric inventory questionnaire. Am J Geriatric Psychiatry. 10.1016/j.jagp.2024.10.014</mixed-citation></citation-alternatives></ref><ref id="CR20"><citation-alternatives><element-citation id="ec-CR20" publication-type="journal"><person-group person-group-type="author"><name><surname>Helvik</surname><given-names>AS</given-names></name><name><surname>Barca</surname><given-names>ML</given-names></name><name><surname>Bergh</surname><given-names>S</given-names></name><etal/></person-group><article-title>The course of depressive symptoms with decline in cognitive function - a longitudinal study of older adults receiving in-home care at baseline</article-title><source>BMC Geriatr</source><year>2019</year><pub-id pub-id-type="doi">10.1186/S12877-019-1226-8</pub-id></element-citation><mixed-citation id="mc-CR20" publication-type="journal">Helvik AS, Barca ML, Bergh S et al (2019) The course of depressive symptoms with decline in cognitive function - a longitudinal study of older adults receiving in-home care at baseline. BMC Geriatr. 10.1186/S12877-019-1226-8</mixed-citation></citation-alternatives></ref><ref id="CR21"><citation-alternatives><element-citation id="ec-CR21" publication-type="book"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>K</given-names></name><name><surname>Riemersma -Van Der Lek RF, Patxot M, </surname></name><etal/></person-group><source>Progression of dementia assessed by temporal correlations of physical activity: results from a 3.5-year, Longitudinal Randomized Controlled Trial OPEN</source><year>2016</year><publisher-name>Nature Publishing Group</publisher-name></element-citation><mixed-citation id="mc-CR21" publication-type="book">Hu K, Riemersma -Van Der Lek RF, Patxot M, et al (2016) Progression of dementia assessed by temporal correlations of physical activity: results from a 3.5-year, Longitudinal Randomized Controlled Trial OPEN. Nature Publishing Group. 10.1038/srep27742</mixed-citation></citation-alternatives></ref><ref id="CR22"><citation-alternatives><element-citation id="ec-CR22" publication-type="journal"><person-group person-group-type="author"><name><surname>Ismail</surname><given-names>Z</given-names></name><name><surname>Elbayoumi</surname><given-names>H</given-names></name><name><surname>Fischer</surname><given-names>CE</given-names></name><etal/></person-group><article-title>Prevalence of depression in patients with mild cognitive impairment: a systematic review and meta-analysis</article-title><source>JAMA Psychiat</source><year>2017</year><volume>74</volume><fpage>58</fpage><lpage>67</lpage><pub-id pub-id-type="doi">10.1001/JAMAPSYCHIATRY.2016.3162</pub-id></element-citation><mixed-citation id="mc-CR22" publication-type="journal">Ismail Z, Elbayoumi H, Fischer CE et al (2017) Prevalence of depression in patients with mild cognitive impairment: a systematic review and meta-analysis. JAMA Psychiat 74:58&#x02013;67. 10.1001/JAMAPSYCHIATRY.2016.3162</mixed-citation></citation-alternatives></ref><ref id="CR23"><citation-alternatives><element-citation id="ec-CR23" publication-type="journal"><person-group person-group-type="author"><name><surname>James</surname><given-names>KE</given-names></name><name><surname>White</surname><given-names>RF</given-names></name><name><surname>Kraemer</surname><given-names>HC</given-names></name></person-group><article-title>Repeated split sample validation to assess logistic regression and recursive partitioning: an application to the prediction of cognitive impairment</article-title><source>Stat Med</source><year>2005</year><volume>24</volume><fpage>3019</fpage><lpage>3035</lpage><pub-id pub-id-type="doi">10.1002/SIM.2154</pub-id><pub-id pub-id-type="pmid">16149128</pub-id>
</element-citation><mixed-citation id="mc-CR23" publication-type="journal">James KE, White RF, Kraemer HC (2005) Repeated split sample validation to assess logistic regression and recursive partitioning: an application to the prediction of cognitive impairment. Stat Med 24:3019&#x02013;3035. 10.1002/SIM.2154<pub-id pub-id-type="pmid">16149128</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR24"><citation-alternatives><element-citation id="ec-CR24" publication-type="journal"><person-group person-group-type="author"><name><surname>Jongsiriyanyong</surname><given-names>S</given-names></name><name><surname>Limpawattana</surname><given-names>P</given-names></name></person-group><article-title>Mild cognitive impairment in clinical practice: a review article</article-title><source>Am J Alzheimer&#x02019;s Dis Dementia</source><year>2018</year><volume>33</volume><fpage>500</fpage><lpage>507</lpage><pub-id pub-id-type="doi">10.1177/1533317518791401</pub-id></element-citation><mixed-citation id="mc-CR24" publication-type="journal">Jongsiriyanyong S, Limpawattana P (2018) Mild cognitive impairment in clinical practice: a review article. Am J Alzheimer&#x02019;s Dis Dementia 33:500&#x02013;507. 10.1177/1533317518791401</mixed-citation></citation-alternatives></ref><ref id="CR25"><citation-alternatives><element-citation id="ec-CR25" publication-type="journal"><person-group person-group-type="author"><name><surname>Knopman</surname><given-names>DS</given-names></name><name><surname>Petersen</surname><given-names>RC</given-names></name></person-group><article-title>Mild cognitive impairment and mild dementia: a clinical perspective</article-title><source>Mayo Clin Proc</source><year>2014</year><volume>89</volume><fpage>1452</fpage><pub-id pub-id-type="doi">10.1016/J.MAYOCP.2014.06.019</pub-id><pub-id pub-id-type="pmid">25282431</pub-id>
</element-citation><mixed-citation id="mc-CR25" publication-type="journal">Knopman DS, Petersen RC (2014) Mild cognitive impairment and mild dementia: a clinical perspective. Mayo Clin Proc 89:1452. 10.1016/J.MAYOCP.2014.06.019<pub-id pub-id-type="pmid">25282431</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR26"><citation-alternatives><element-citation id="ec-CR26" publication-type="journal"><person-group person-group-type="author"><name><surname>Kourtesis</surname><given-names>P</given-names></name><name><surname>Margioti</surname><given-names>E</given-names></name><name><surname>Demenega</surname><given-names>C</given-names></name><etal/></person-group><article-title>A comparison of the greek ACE-III, M-ACE, ACE-R, MMSE, and ECAS in the assessment and identification of Alzheimer&#x02019;s disease</article-title><source>J Int Neuropsychol Soc</source><year>2020</year><volume>26</volume><fpage>825</fpage><lpage>834</lpage><pub-id pub-id-type="doi">10.1017/S1355617720000314</pub-id><pub-id pub-id-type="pmid">32312343</pub-id>
</element-citation><mixed-citation id="mc-CR26" publication-type="journal">Kourtesis P, Margioti E, Demenega C et al (2020) A comparison of the greek ACE-III, M-ACE, ACE-R, MMSE, and ECAS in the assessment and identification of Alzheimer&#x02019;s disease. J Int Neuropsychol Soc 26:825&#x02013;834. 10.1017/S1355617720000314<pub-id pub-id-type="pmid">32312343</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR27"><citation-alternatives><element-citation id="ec-CR27" publication-type="journal"><person-group person-group-type="author"><name><surname>Lagan&#x000e0;</surname><given-names>V</given-names></name><name><surname>Bruno</surname><given-names>F</given-names></name><name><surname>Altomari</surname><given-names>N</given-names></name><etal/></person-group><article-title>Neuropsychiatric or behavioral and psychological symptoms of dementia (BPSD): focus on prevalence and natural history in Alzheimer&#x02019;s disease and frontotemporal dementia</article-title><source>Front Neurol</source><year>2022</year><volume>13</volume><fpage>832199</fpage><pub-id pub-id-type="doi">10.3389/FNEUR.2022.832199/BIBTEX</pub-id><pub-id pub-id-type="pmid">35812082</pub-id>
</element-citation><mixed-citation id="mc-CR27" publication-type="journal">Lagan&#x000e0; V, Bruno F, Altomari N et al (2022) Neuropsychiatric or behavioral and psychological symptoms of dementia (BPSD): focus on prevalence and natural history in Alzheimer&#x02019;s disease and frontotemporal dementia. Front Neurol 13:832199. 10.3389/FNEUR.2022.832199/BIBTEX<pub-id pub-id-type="pmid">35812082</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR28"><citation-alternatives><element-citation id="ec-CR28" publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>J</given-names></name></person-group><article-title>Mild cognitive impairment in relation to Alzheimer&#x02019;s disease: an investigation of principles, classifications, ethics, and problems</article-title><source>Neuroethics</source><year>2023</year><volume>16</volume><fpage>1</fpage><lpage>18</lpage><pub-id pub-id-type="doi">10.1007/S12152-023-09522-5</pub-id></element-citation><mixed-citation id="mc-CR28" publication-type="journal">Lee J (2023) Mild cognitive impairment in relation to Alzheimer&#x02019;s disease: an investigation of principles, classifications, ethics, and problems. Neuroethics 16:1&#x02013;18. 10.1007/S12152-023-09522-5</mixed-citation></citation-alternatives></ref><ref id="CR29"><citation-alternatives><element-citation id="ec-CR29" publication-type="journal"><person-group person-group-type="author"><name><surname>Leung</surname><given-names>DKY</given-names></name><name><surname>Chan</surname><given-names>WC</given-names></name><name><surname>Spector</surname><given-names>A</given-names></name><name><surname>Wong</surname><given-names>GHY</given-names></name></person-group><article-title>Prevalence of depression, anxiety, and apathy symptoms across dementia stages: a systematic review and meta-analysis</article-title><source>Int J Geriatr Psychiatry</source><year>2021</year><volume>36</volume><fpage>1330</fpage><lpage>1344</lpage><pub-id pub-id-type="doi">10.1002/GPS.5556</pub-id><pub-id pub-id-type="pmid">33905138</pub-id>
</element-citation><mixed-citation id="mc-CR29" publication-type="journal">Leung DKY, Chan WC, Spector A, Wong GHY (2021) Prevalence of depression, anxiety, and apathy symptoms across dementia stages: a systematic review and meta-analysis. Int J Geriatr Psychiatry 36:1330&#x02013;1344. 10.1002/GPS.5556<pub-id pub-id-type="pmid">33905138</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR30"><citation-alternatives><element-citation id="ec-CR30" publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>J</given-names></name><name><surname>Hu</surname><given-names>H</given-names></name><name><surname>Bai</surname><given-names>Y</given-names></name></person-group><article-title>Generalized radial basis function neural network based on an improved dynamic particle swarm optimization and adaboost algorithm</article-title><source>Neurocomput</source><year>2015</year><volume>152</volume><fpage>305</fpage><lpage>315</lpage><pub-id pub-id-type="doi">10.1016/j.neucom.2014.10.065</pub-id></element-citation><mixed-citation id="mc-CR30" publication-type="journal">Lu J, Hu H, Bai Y (2015) Generalized radial basis function neural network based on an improved dynamic particle swarm optimization and adaboost algorithm. Neurocomput 152:305&#x02013;315. 10.1016/j.neucom.2014.10.065</mixed-citation></citation-alternatives></ref><ref id="CR31"><citation-alternatives><element-citation id="ec-CR31" publication-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname><given-names>E</given-names></name><name><surname>Velayudhan</surname><given-names>L</given-names></name></person-group><article-title>Neuropsychiatric symptoms in mild cognitive impairment: a literature review</article-title><source>Dement Geriatr Cogn Disord</source><year>2020</year><volume>49</volume><fpage>146</fpage><lpage>155</lpage><pub-id pub-id-type="doi">10.1159/000507078</pub-id><pub-id pub-id-type="pmid">32289790</pub-id>
</element-citation><mixed-citation id="mc-CR31" publication-type="journal">Martin E, Velayudhan L (2020) Neuropsychiatric symptoms in mild cognitive impairment: a literature review. Dement Geriatr Cogn Disord 49:146&#x02013;155. 10.1159/000507078<pub-id pub-id-type="pmid">32289790</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR32"><citation-alternatives><element-citation id="ec-CR32" publication-type="journal"><person-group person-group-type="author"><name><surname>McKhann</surname><given-names>GM</given-names></name><name><surname>Knopman</surname><given-names>DS</given-names></name><name><surname>Chertkow</surname><given-names>H</given-names></name><etal/></person-group><article-title>The diagnosis of dementia due to Alzheimer&#x02019;s disease: Recommendations from the National Institute on Aging-Alzheimer&#x02019;s Association workgroups on diagnostic guidelines for Alzheimer&#x02019;s disease</article-title><source>Alzheimers Dement</source><year>2011</year><volume>7</volume><fpage>263</fpage><pub-id pub-id-type="doi">10.1016/J.JALZ.2011.03.005</pub-id><pub-id pub-id-type="pmid">21514250</pub-id>
</element-citation><mixed-citation id="mc-CR32" publication-type="journal">McKhann GM, Knopman DS, Chertkow H et al (2011) The diagnosis of dementia due to Alzheimer&#x02019;s disease: Recommendations from the National Institute on Aging-Alzheimer&#x02019;s Association workgroups on diagnostic guidelines for Alzheimer&#x02019;s disease. Alzheimers Dement 7:263. 10.1016/J.JALZ.2011.03.005<pub-id pub-id-type="pmid">21514250</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR33"><citation-alternatives><element-citation id="ec-CR33" publication-type="journal"><person-group person-group-type="author"><name><surname>Ndichu</surname><given-names>S</given-names></name><name><surname>Ban</surname><given-names>T</given-names></name><name><surname>Takahashi</surname><given-names>T</given-names></name><name><surname>Inoue</surname><given-names>D</given-names></name></person-group><article-title>AI-assisted security alert data analysis with imbalanced learning methods</article-title><source>Appl Sci</source><year>2023</year><pub-id pub-id-type="doi">10.3390/app13031977</pub-id></element-citation><mixed-citation id="mc-CR33" publication-type="journal">Ndichu S, Ban T, Takahashi T, Inoue D (2023) AI-assisted security alert data analysis with imbalanced learning methods. Appl Sci. 10.3390/app13031977</mixed-citation></citation-alternatives></ref><ref id="CR34"><citation-alternatives><element-citation id="ec-CR34" publication-type="journal"><person-group person-group-type="author"><name><surname>Ng</surname><given-names>KP</given-names></name><name><surname>Chiew</surname><given-names>H</given-names></name><name><surname>Rosa-Neto</surname><given-names>P</given-names></name><etal/></person-group><article-title>Associations of AT(N) biomarkers with neuropsychiatric symptoms in preclinical Alzheimer&#x02019;s disease and cognitively unimpaired individuals</article-title><source>Transl Neurodegener</source><year>2021</year><volume>10</volume><fpage>1</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1186/S40035-021-00236-3/TABLES/2</pub-id><pub-id pub-id-type="pmid">33390174</pub-id>
</element-citation><mixed-citation id="mc-CR34" publication-type="journal">Ng KP, Chiew H, Rosa-Neto P et al (2021) Associations of AT(N) biomarkers with neuropsychiatric symptoms in preclinical Alzheimer&#x02019;s disease and cognitively unimpaired individuals. Transl Neurodegener 10:1&#x02013;14. 10.1186/S40035-021-00236-3/TABLES/2<pub-id pub-id-type="pmid">33390174</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR35"><citation-alternatives><element-citation id="ec-CR35" publication-type="journal"><person-group person-group-type="author"><name><surname>Nichols</surname><given-names>E</given-names></name><name><surname>Steinmetz</surname><given-names>JD</given-names></name><name><surname>Vollset</surname><given-names>SE</given-names></name><etal/></person-group><article-title>Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019</article-title><source>Lancet Public Health</source><year>2022</year><volume>7</volume><fpage>e105</fpage><lpage>e125</lpage><pub-id pub-id-type="doi">10.1016/S2468-2667(21)00249-8</pub-id><pub-id pub-id-type="pmid">34998485</pub-id>
</element-citation><mixed-citation id="mc-CR35" publication-type="journal">Nichols E, Steinmetz JD, Vollset SE et al (2022) Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019. Lancet Public Health 7:e105&#x02013;e125. 10.1016/S2468-2667(21)00249-8<pub-id pub-id-type="pmid">34998485</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR36"><citation-alternatives><element-citation id="ec-CR36" publication-type="journal"><person-group person-group-type="author"><name><surname>O&#x02019;Shea</surname><given-names>DM</given-names></name><name><surname>Dotson</surname><given-names>VM</given-names></name><name><surname>Woods</surname><given-names>AJ</given-names></name><etal/></person-group><article-title>Depressive symptom dimensions and their association with hippocampal and entorhinal cortex volumes in community dwelling older adults</article-title><source>Front Aging Neurosci</source><year>2018</year><pub-id pub-id-type="doi">10.3389/FNAGI.2018.00040</pub-id></element-citation><mixed-citation id="mc-CR36" publication-type="journal">O&#x02019;Shea DM, Dotson VM, Woods AJ et al (2018) Depressive symptom dimensions and their association with hippocampal and entorhinal cortex volumes in community dwelling older adults. Front Aging Neurosci. 10.3389/FNAGI.2018.00040</mixed-citation></citation-alternatives></ref><ref id="CR37"><citation-alternatives><element-citation id="ec-CR37" publication-type="journal"><person-group person-group-type="author"><name><surname>Petersen</surname><given-names>RC</given-names></name></person-group><article-title>Mild cognitive impairment as a diagnostic entity</article-title><source>J Intern Med</source><year>2004</year><volume>256</volume><fpage>183</fpage><lpage>194</lpage><pub-id pub-id-type="doi">10.1111/J.1365-2796.2004.01388.X</pub-id><pub-id pub-id-type="pmid">15324362</pub-id>
</element-citation><mixed-citation id="mc-CR37" publication-type="journal">Petersen RC (2004) Mild cognitive impairment as a diagnostic entity. J Intern Med 256:183&#x02013;194. 10.1111/J.1365-2796.2004.01388.X<pub-id pub-id-type="pmid">15324362</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR38"><citation-alternatives><element-citation id="ec-CR38" publication-type="journal"><person-group person-group-type="author"><name><surname>Rahimi</surname><given-names>J</given-names></name><name><surname>Kovacs</surname><given-names>GG</given-names></name></person-group><article-title>Prevalence of mixed pathologies in the aging brain</article-title><source>Alzheimers Res Ther</source><year>2014</year><volume>6</volume><fpage>1</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1186/S13195-014-0082-1/FIGURES/2</pub-id><pub-id pub-id-type="pmid">24382028</pub-id>
</element-citation><mixed-citation id="mc-CR38" publication-type="journal">Rahimi J, Kovacs GG (2014) Prevalence of mixed pathologies in the aging brain. Alzheimers Res Ther 6:1&#x02013;11. 10.1186/S13195-014-0082-1/FIGURES/2<pub-id pub-id-type="pmid">24382028</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR39"><citation-alternatives><element-citation id="ec-CR39" publication-type="journal"><person-group person-group-type="author"><name><surname>Saari</surname><given-names>TT</given-names></name></person-group><article-title>Empirical and authoritative classification of neuropsychiatric syndromes in neurocognitive disorders</article-title><source>J Neuropsychiatry Clin Neurosci</source><year>2022</year><pub-id pub-id-type="doi">10.1176/APPI.NEUROPSYCH.21100249</pub-id></element-citation><mixed-citation id="mc-CR39" publication-type="journal">Saari TT (2022) Empirical and authoritative classification of neuropsychiatric syndromes in neurocognitive disorders. J Neuropsychiatry Clin Neurosci. 10.1176/APPI.NEUROPSYCH.21100249</mixed-citation></citation-alternatives></ref><ref id="CR40"><citation-alternatives><element-citation id="ec-CR40" publication-type="journal"><person-group person-group-type="author"><name><surname>Sachdev</surname><given-names>PS</given-names></name><name><surname>Blacker</surname><given-names>D</given-names></name><name><surname>Blazer</surname><given-names>DG</given-names></name><etal/></person-group><article-title>Classifying neurocognitive disorders: the DSM-5 approach</article-title><source>Nat Rev Neurol</source><year>2014</year><volume>10</volume><fpage>634</fpage><lpage>642</lpage><pub-id pub-id-type="doi">10.1038/NRNEUROL.2014.181</pub-id><pub-id pub-id-type="pmid">25266297</pub-id>
</element-citation><mixed-citation id="mc-CR40" publication-type="journal">Sachdev PS, Blacker D, Blazer DG et al (2014) Classifying neurocognitive disorders: the DSM-5 approach. Nat Rev Neurol 10:634&#x02013;642. 10.1038/NRNEUROL.2014.181<pub-id pub-id-type="pmid">25266297</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR41"><citation-alternatives><element-citation id="ec-CR41" publication-type="journal"><person-group person-group-type="author"><name><surname>Sarker</surname><given-names>IH</given-names></name></person-group><article-title>Machine learning: algorithms, real-world applications and research directions</article-title><source>SN Comput Sci</source><year>2021</year><volume>2</volume><fpage>1</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1007/S42979-021-00592-X/FIGURES/11</pub-id></element-citation><mixed-citation id="mc-CR41" publication-type="journal">Sarker IH (2021) Machine learning: algorithms, real-world applications and research directions. SN Comput Sci 2:1&#x02013;21. 10.1007/S42979-021-00592-X/FIGURES/11</mixed-citation></citation-alternatives></ref><ref id="CR42"><citation-alternatives><element-citation id="ec-CR42" publication-type="journal"><person-group person-group-type="author"><name><surname>Scott</surname><given-names>H</given-names></name></person-group><article-title>The changing self: The impact of dementia on the personal and social identity of women (findings from the Improving the Experience of Dementia and Enhancing Active Life programme)</article-title><source>Dementia (London)</source><year>2022</year><volume>21</volume><fpage>503</fpage><lpage>518</lpage><pub-id pub-id-type="doi">10.1177/14713012211047351</pub-id><pub-id pub-id-type="pmid">34636699</pub-id>
</element-citation><mixed-citation id="mc-CR42" publication-type="journal">Scott H (2022) The changing self: The impact of dementia on the personal and social identity of women (findings from the Improving the Experience of Dementia and Enhancing Active Life programme). Dementia (London) 21:503&#x02013;518. 10.1177/14713012211047351<pub-id pub-id-type="pmid">34636699</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR43"><mixed-citation publication-type="other">Shahri NHNBM, Lai SBS, Mohamad M, et al (2021) Comparing the Performance of AdaBoost, XGBoost, and Logistic Regression for Imbalanced Data. Mathematics and Statistics</mixed-citation></ref><ref id="CR44"><citation-alternatives><element-citation id="ec-CR44" publication-type="journal"><person-group person-group-type="author"><name><surname>Shin</surname><given-names>C</given-names></name><name><surname>Park</surname><given-names>MH</given-names></name><name><surname>Lee</surname><given-names>SH</given-names></name><etal/></person-group><article-title>Usefulness of the 15-item geriatric depression scale (GDS-15) for classifying minor and major depressive disorders among community-dwelling elders</article-title><source>J Affect Disord</source><year>2019</year><volume>259</volume><fpage>370</fpage><lpage>375</lpage><pub-id pub-id-type="doi">10.1016/J.JAD.2019.08.053</pub-id><pub-id pub-id-type="pmid">31470180</pub-id>
</element-citation><mixed-citation id="mc-CR44" publication-type="journal">Shin C, Park MH, Lee SH et al (2019) Usefulness of the 15-item geriatric depression scale (GDS-15) for classifying minor and major depressive disorders among community-dwelling elders. J Affect Disord 259:370&#x02013;375. 10.1016/J.JAD.2019.08.053<pub-id pub-id-type="pmid">31470180</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR45"><citation-alternatives><element-citation id="ec-CR45" publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>GS</given-names></name><name><surname>Workman</surname><given-names>CI</given-names></name><name><surname>Protas</surname><given-names>H</given-names></name><etal/></person-group><article-title>Positron emission tomography imaging of serotonin degeneration and beta-amyloid deposition in late-life depression evaluated with multi-modal partial least squares</article-title><source>Transl Psychiatry</source><year>2021</year><pub-id pub-id-type="doi">10.1038/S41398-021-01539-9</pub-id></element-citation><mixed-citation id="mc-CR45" publication-type="journal">Smith GS, Workman CI, Protas H et al (2021) Positron emission tomography imaging of serotonin degeneration and beta-amyloid deposition in late-life depression evaluated with multi-modal partial least squares. Transl Psychiatry. 10.1038/S41398-021-01539-9</mixed-citation></citation-alternatives></ref><ref id="CR46"><citation-alternatives><element-citation id="ec-CR46" publication-type="journal"><person-group person-group-type="author"><name><surname>Spampinato</surname><given-names>MV</given-names></name><name><surname>Ulber</surname><given-names>JL</given-names></name><name><surname>Fayyaz</surname><given-names>H</given-names></name><etal/></person-group><article-title>Neuropsychiatric symptoms and in vivo Alzheimer&#x02019;s biomarkers in mild cognitive impairment</article-title><source>J Alzheimers Dis</source><year>2023</year><volume>96</volume><fpage>1827</fpage><lpage>1836</lpage><pub-id pub-id-type="doi">10.3233/JAD-220835</pub-id><pub-id pub-id-type="pmid">38007644</pub-id>
</element-citation><mixed-citation id="mc-CR46" publication-type="journal">Spampinato MV, Ulber JL, Fayyaz H et al (2023) Neuropsychiatric symptoms and in vivo Alzheimer&#x02019;s biomarkers in mild cognitive impairment. J Alzheimers Dis 96:1827&#x02013;1836. 10.3233/JAD-220835<pub-id pub-id-type="pmid">38007644</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR47"><citation-alternatives><element-citation id="ec-CR47" publication-type="journal"><person-group person-group-type="author"><name><surname>Thombs</surname><given-names>BD</given-names></name><name><surname>Kwakkenbos</surname><given-names>L</given-names></name><name><surname>Levis</surname><given-names>AW</given-names></name><name><surname>Benedetti</surname><given-names>A</given-names></name></person-group><article-title>Addressing overestimation of the prevalence of depression based on self-report screening questionnaires</article-title><source>CMAJ</source><year>2018</year><volume>190</volume><fpage>E44</fpage><lpage>E49</lpage><pub-id pub-id-type="doi">10.1503/CMAJ.170691/-/DC1</pub-id><pub-id pub-id-type="pmid">29335262</pub-id>
</element-citation><mixed-citation id="mc-CR47" publication-type="journal">Thombs BD, Kwakkenbos L, Levis AW, Benedetti A (2018) Addressing overestimation of the prevalence of depression based on self-report screening questionnaires. CMAJ 190:E44&#x02013;E49. 10.1503/CMAJ.170691/-/DC1<pub-id pub-id-type="pmid">29335262</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR48"><citation-alternatives><element-citation id="ec-CR48" publication-type="journal"><person-group person-group-type="author"><name><surname>Van Stralen</surname><given-names>KJ</given-names></name><name><surname>Stel</surname><given-names>VS</given-names></name><name><surname>Reitsma</surname><given-names>JB</given-names></name><etal/></person-group><article-title>Diagnostic methods I: sensitivity, specificity, and other measures of accuracy</article-title><source>Kidney Int</source><year>2009</year><volume>75</volume><fpage>1257</fpage><lpage>1263</lpage><pub-id pub-id-type="doi">10.1038/KI.2009.92</pub-id><pub-id pub-id-type="pmid">19340091</pub-id>
</element-citation><mixed-citation id="mc-CR48" publication-type="journal">Van Stralen KJ, Stel VS, Reitsma JB et al (2009) Diagnostic methods I: sensitivity, specificity, and other measures of accuracy. Kidney Int 75:1257&#x02013;1263. 10.1038/KI.2009.92<pub-id pub-id-type="pmid">19340091</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR49"><citation-alternatives><element-citation id="ec-CR49" publication-type="journal"><person-group person-group-type="author"><name><surname>Vega</surname><given-names>JN</given-names></name><name><surname>Newhouse</surname><given-names>PA</given-names></name></person-group><article-title>Mild cognitive impairment: diagnosis, longitudinal course, and emerging treatments</article-title><source>Curr Psychiatry Rep</source><year>2014</year><volume>16</volume><fpage>490</fpage><pub-id pub-id-type="doi">10.1007/S11920-014-0490-8</pub-id><pub-id pub-id-type="pmid">25160795</pub-id>
</element-citation><mixed-citation id="mc-CR49" publication-type="journal">Vega JN, Newhouse PA (2014) Mild cognitive impairment: diagnosis, longitudinal course, and emerging treatments. Curr Psychiatry Rep 16:490. 10.1007/S11920-014-0490-8<pub-id pub-id-type="pmid">25160795</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR50"><citation-alternatives><element-citation id="ec-CR50" publication-type="journal"><person-group person-group-type="author"><name><surname>Vlachos</surname><given-names>GS</given-names></name><name><surname>Kosmidis</surname><given-names>MH</given-names></name><name><surname>Yannakoulia</surname><given-names>M</given-names></name><etal/></person-group><article-title>Incidence of mild cognitive impairment in the elderly population in Greece: results from the HELIAD study</article-title><source>Aging Clin Exp Res</source><year>2021</year><volume>33</volume><fpage>2679</fpage><lpage>2688</lpage><pub-id pub-id-type="doi">10.1007/s40520-021-01819-w</pub-id><pub-id pub-id-type="pmid">33686543</pub-id>
</element-citation><mixed-citation id="mc-CR50" publication-type="journal">Vlachos GS, Kosmidis MH, Yannakoulia M et al (2021) Incidence of mild cognitive impairment in the elderly population in Greece: results from the HELIAD study. Aging Clin Exp Res 33:2679&#x02013;2688. 10.1007/s40520-021-01819-w<pub-id pub-id-type="pmid">33686543</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR51"><citation-alternatives><element-citation id="ec-CR51" publication-type="journal"><person-group person-group-type="author"><name><surname>Zenebe</surname><given-names>Y</given-names></name><name><surname>Akele</surname><given-names>B</given-names></name><name><surname>W, Selassie M, Necho M, </surname></name></person-group><article-title>Prevalence and determinants of depression among old age: a systematic review and meta-analysis</article-title><source>Ann Gen Psychiatry</source><year>2021</year><pub-id pub-id-type="doi">10.1186/S12991-021-00375-X</pub-id></element-citation><mixed-citation id="mc-CR51" publication-type="journal">Zenebe Y, Akele B, W, Selassie M, Necho M, (2021) Prevalence and determinants of depression among old age: a systematic review and meta-analysis. Ann Gen Psychiatry. 10.1186/S12991-021-00375-X</mixed-citation></citation-alternatives></ref><ref id="CR52"><citation-alternatives><element-citation id="ec-CR52" publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>S</given-names></name><name><surname>Qiu</surname><given-names>Q</given-names></name><name><surname>Qian</surname><given-names>S</given-names></name><etal/></person-group><article-title>Determining appropriate screening tools and cutoffs for cognitive impairment in the Chinese elderly</article-title><source>Front Psychiatry</source><year>2021</year><pub-id pub-id-type="doi">10.3389/FPSYT.2021.773281</pub-id></element-citation><mixed-citation id="mc-CR52" publication-type="journal">Zhang S, Qiu Q, Qian S et al (2021) Determining appropriate screening tools and cutoffs for cognitive impairment in the Chinese elderly. Front Psychiatry. 10.3389/FPSYT.2021.773281</mixed-citation></citation-alternatives></ref><ref id="CR53"><citation-alternatives><element-citation id="ec-CR53" publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>J</given-names></name><name><surname>Zou</surname><given-names>H</given-names></name><name><surname>Rosset</surname><given-names>Z</given-names></name><name><surname>Hastie</surname><given-names>T</given-names></name></person-group><article-title>Multi-class AdaBoost</article-title><source>Stat Interface</source><year>2009</year><volume>2</volume><fpage>349</fpage><lpage>360</lpage><pub-id pub-id-type="doi">10.4310/SII.2009.v2.n3.a8</pub-id></element-citation><mixed-citation id="mc-CR53" publication-type="journal">Zhu J, Zou H, Rosset Z, Hastie T (2009) Multi-class AdaBoost. Stat Interface 2:349&#x02013;360</mixed-citation></citation-alternatives></ref></ref-list></back></article>